<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85008</article-id><article-id pub-id-type="doi">10.7554/eLife.85008</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Molecular basis of interactions between CaMKII and α-actinin-2 that underlie dendritic spine enlargement</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-300078"><name><surname>Curtis</surname><given-names>Ashton J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-8320-0169</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-300079"><name><surname>Zhu</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300080"><name><surname>Penny</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166913"><name><surname>Gold</surname><given-names>Matthew G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1281-0815</contrib-id><email>m.gold@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r9qc142</institution-id><institution>Department of Neuroscience, Physiology and Pharmacology, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Saneyoshi</surname><given-names>Takeo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Kyoto University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>07</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85008</elocation-id><history><date date-type="received" iso-8601-date="2022-11-18"><day>18</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-07-24"><day>24</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-12-05"><day>05</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.12.04.519035"/></event></pub-history><permissions><copyright-statement>© 2023, Curtis, Zhu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Curtis, Zhu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85008-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-85008-figures-v3.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" xlink:href="10.7554/elife.91566" id="ra1"/><abstract><p>Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) is essential for long-term potentiation (LTP) of excitatory synapses that is linked to learning and memory. In this study, we focused on understanding how interactions between CaMKIIα and the actin-crosslinking protein α-actinin-2 underlie long-lasting changes in dendritic spine architecture. We found that association of the two proteins was unexpectedly elevated within 2 minutes of NMDA receptor stimulation that triggers structural LTP in primary hippocampal neurons. Furthermore, disruption of interactions between the two proteins prevented the accumulation of enlarged mushroom-type dendritic spines following NMDA receptor activation. α-Actinin-2 binds to the regulatory segment of CaMKII. Calorimetry experiments, and a crystal structure of α-actinin-2 EF hands 3 and 4 in complex with the CaMKII regulatory segment, indicate that the regulatory segment of autoinhibited CaMKII is not fully accessible to α-actinin-2. Pull-down experiments show that occupation of the CaMKII substrate-binding groove by GluN2B markedly increases α-actinin-2 access to the CaMKII regulatory segment. Furthermore, in situ labelling experiments are consistent with the notion that recruitment of CaMKII to NMDA receptors contributes to elevated interactions between the kinase and α-actinin-2 during structural LTP. Overall, our study provides new mechanistic insight into the molecular basis of structural LTP and reveals an added layer of sophistication to the function of CaMKII.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CaMKII</kwd><kwd>actinin</kwd><kwd>long-term potentiation</kwd><kwd>synapse</kwd><kwd>dendritic spine</kwd><kwd>protein kinase</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>104194/Z/14/Z</award-id><principal-award-recipient><name><surname>Gold</surname><given-names>Matthew G</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/N015274/1</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Jian</given-names></name><name><surname>Penny</surname><given-names>Christopher J</given-names></name><name><surname>Gold</surname><given-names>Matthew G</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>2081382</award-id><principal-award-recipient><name><surname>Curtis</surname><given-names>Ashton J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>CaMKII and the actin-crosslinking protein α-actinin-2 associate within minutes of the induction of long-term potentiation and disrupting this interaction prevents formation of enlarged dendritic spines.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Changes in synaptic connections between neurons are fundamental to learning and memory (<xref ref-type="bibr" rid="bib11">Citri and Malenka, 2008</xref>). Calmodulin-dependent protein kinase II (CaMKII) plays a central role in long-term potentiation (LTP) of excitatory synapses following influxes of Ca<sup>2+</sup> into postsynaptic spines (<xref ref-type="bibr" rid="bib25">Hell, 2014</xref>). Activation of CaMKII by Ca<sup>2+</sup>/CaM leads to phosphorylation of postsynaptic proteins including AMPA-type glutamate receptors which has the overall effect of increasing postsynaptic responsiveness to glutamate release (<xref ref-type="bibr" rid="bib1">Anggono and Huganir, 2012</xref>). CaMKII also serves a structural function in LTP (<xref ref-type="bibr" rid="bib27">Hojjati et al., 2007</xref>) by nucleating networks of protein-protein interactions through its modular oligomeric structure (<xref ref-type="bibr" rid="bib6">Bhattacharyya et al., 2020</xref>), consistent with its extremely high abundance in dendritic spines (<xref ref-type="bibr" rid="bib16">Erondu and Kennedy, 1985</xref>). CaMKII holoenzymes form through oligomerisation of the C-terminal hub domains of 12 subunits (<xref ref-type="bibr" rid="bib9">Chao et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Myers et al., 2017</xref>). The hub domains assemble into a two-tiered central ring from which the N-terminal kinase domains radiate (<xref ref-type="bibr" rid="bib9">Chao et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Myers et al., 2017</xref>). Binding of Ca<sup>2+</sup>/CaM to a central regulatory segment releases the segment from the kinase domain enabling access to substrates and interaction partners (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). The CaMKII kinase domain has many documented substrates and binding partners (<xref ref-type="bibr" rid="bib39">Özden et al., 2020</xref>). Formation of a highly stable complex between the CaMKII kinase domain and the C-terminal tail of NMDA receptor (NMDAR) GluN2B subunits is thought to be critically important for learning and memory (<xref ref-type="bibr" rid="bib53">Sanhueza et al., 2011</xref>). Unlike the promiscuous kinase domain, the regulatory segment of CaMKIIα interacts only with α-actinins (<xref ref-type="bibr" rid="bib15">Dhavan et al., 2002</xref>; <xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>) besides CaM, while the sole binding partner of the hub domain is densin-180 (<xref ref-type="bibr" rid="bib62">Strack et al., 2000b</xref>). Understanding how and when the regulatory and hub regions of CaMKII engage in these interactions is essential for a complete understanding of the structural role of CaMKII in LTP (<xref ref-type="bibr" rid="bib25">Hell, 2014</xref>).</p><p>α-Actinins are structural proteins that form antiparallel rod-like dimers (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>). In the heart, they are a key component of Z-discs where they crosslink actin filaments to titin (<xref ref-type="bibr" rid="bib72">Young et al., 1998</xref>). In dendritic spines, α-actinins serve a more complex function with many additional binding partners including CaMKII, NMDARs (<xref ref-type="bibr" rid="bib69">Wyszynski et al., 1997</xref>), PSD-95 (<xref ref-type="bibr" rid="bib32">Matt et al., 2018</xref>), CaV1.2s (<xref ref-type="bibr" rid="bib22">Hall et al., 2013</xref>), and densin-180 (<xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>). Three of the four α-actinin isoforms have been detected in the postsynaptic density (<xref ref-type="bibr" rid="bib65">Walikonis et al., 2000</xref>). The most abundant is α-actinin-2, which localises to dendritic spines of excitatory synapses (<xref ref-type="bibr" rid="bib46">Rao et al., 1998</xref>; <xref ref-type="bibr" rid="bib70">Wyszynski et al., 1998</xref>) where it interacts with the CaMKII regulatory segment independent of Ca<sup>2+</sup> through its third and fourth EF hands close to its C-terminus (gold, <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). Association with actinin only weakly stimulates the activity of CaMKII towards certain substrates (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Robison et al., 2005a</xref>), therefore the interaction is thought to serve a structural role. Immunogold labelling shows that α-actinin-2 is present within the postsynaptic density (<xref ref-type="bibr" rid="bib70">Wyszynski et al., 1998</xref>). Knockdown or overexpression of α-actinin-2 in cultured hippocampal neurons leads to defects in spine formation, with α-actinin-2 knockdown breaking the link between NMDAR activation and spine enlargement (<xref ref-type="bibr" rid="bib26">Hodges et al., 2014</xref>) – a process known as structural LTP.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Changes in association of α-actinin-2 and calmodulin-dependent protein kinase II (CaMKII) following NMDA receptor (NMDAR) activation.</title><p>(<bold>A</bold>) Topologies of α-actinin-2 constructs expressed in neurons. (<bold>B</bold>) and (<bold>C</bold>) show anti-GFP immunofluorescence (left column) and anti-CaMKII⍺/anti-FLAG proximity ligation assay (PLA) puncta (middle column) in primary hippocampal neurons expressing FLAG-α-actinin-2 wild-type (WT) with GFP either before (<bold>B</bold>) or after (<bold>C</bold>) NMDAR activation. Scale bars are 20 μm (whole neuron images) and 1 μm (dendrite close-ups). (<bold>D</bold>) Quantitation of PLA puncta per 10 μm dendrite before (black) and after (green) NMDAR activation for the full range of α-actinin-2 constructs. Data are presented as the mean ± standard error (SE) and were collected from three independent cultures with the exception of ∆EF1–4 (one culture). The number of neurons analysed for each construct is shown in parentheses. Statistical comparisons were performed using unpaired two-tailed Student’s t-tests (***p &lt; 0.001).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Full proximity ligation assay (PLA) dataset.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Proximity ligation assay (PLA) imaging of calmodulin-dependent protein kinase IIα (CaMKIIα) association with fragments of α-actinin-2.</title><p>Each panel shows anti-GFP immunofluorescence (left columns) and anti-CaMKIIα/anti-FLAG PLA puncta (middle columns) in primary hippocampal neurons either before (upper row) or after (lower row) NMDA receptor (NMDAR) activation. The images correspond to transfections with GFP alone (<bold>A</bold>), or GFP in combination with either α-actinin-2 EF1–4 (<bold>B</bold>), ∆EF1–4 (<bold>C</bold>), ∆PDZ (<bold>D</bold>), or EF1–4 ∆PDZ (<bold>E</bold>). Scale bars correspond to 20 μm (whole neuron images) and 1 μm (dendrite close-ups).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Frequency of FLAG-α-actinin-2/calmodulin-dependent protein kinase II (CaMKII) puncta by spine type.</title><p>The plot shows the proportion of stubby, thin and mushroom-type spines containing proximity ligation assay (PLA) puncta after fixing primary hippocampal neurons either before (black) or 4 hr after NMDA receptor (NMDAR) activation (green). The proportion of PLA-positive spines was greater in mushroom-type spines compared to either stubby type (p=4 × 10<sup>–6</sup> naive, p=3 × 10<sup>–10</sup> post-NMDAR activation using two-tailed paired t-tests) or thin type (p=2 × 10<sup>–5</sup> pre, p=1 × 10<sup>–10</sup> post).</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Full dataset for anti-FLAG/anti-calmodulin-dependent protein kinase IIα (anti-CaMKIIα) proximity ligation assay (PLA) puncta frequency by spine type in neurons expressing FLAG-α-actinin-2.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig1-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig1-figsupp2-v3.tif"/></fig></fig-group><p>Given that α-actinin-2 is known to bind both CaMKII and actin filaments – and is required for spine enlargement – it would be logical if it bridged the two to support the structure of enlarged spine heads that accumulate following LTP. However, this model is at odds with the observation that Ca<sup>2+</sup>/CaM (which activates CaMKII during LTP induction) competes with α-actinin-2 for binding to the CaMKII regulatory segment in vitro (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>), undermining the notion that the two associate following CaMKII activation to bring about structural LTP. In this study, we have focused on reconciling these apparently contradictory observations. We employed in situ labelling in primary hippocampal neurons to reveal changes in association of CaMKIIα and α-actinin-2 following an NMDAR stimulation protocol that triggers structural LTP. We also examined the effect of disrupting the actinin-CaMKII interface on spine head enlargement triggered by NMDAR activation. We used isothermal titration calorimetry (ITC) and crystallography to determine whether the CaMKII kinase domain occludes access of α-actinin-2 to the regulatory segment in the inactive enzyme, and we have identified a potential mechanism for increasing access to the regulatory segment following induction of LTP. This combination of experiments has enabled us to put forward a more coherent molecular model of structural LTP.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Association of CaMKII and α-actinin-2 is elevated following spine head enlargement</title><p>To investigate actinin association with CaMKII in neurons, we utilised proximity ligation assays (PLAs). We developed a set of vectors for mammalian expression of different fragments of α-actinin-2 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) in tandem with GFP. Each α-actinin-2 construct bears an N-terminal FLAG tag, so association with CaMKII can be monitored by PLA using paired anti-FLAG and anti-CaMKIIα antibodies. We transfected each construct in rat primary hippocampal neurons after 10 days in vitro (DIV10), and fixed the mature neurons on DIV14 for imaging anti-GFP immunofluorescence and α-actinin-2-CaMKIIα PLA puncta. For wild-type (WT) α-actinin-2, PLA puncta were visible in dendritic spines in unstimulated neurons (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, arrow) at a density of 0.35±0.05 puncta per 10 µm dendrite (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) – 3.6-fold higher (p=2.2 × 10<sup>–5</sup>) than in unstimulated neurons expressing GFP alone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). To investigate the notion that interactions between actinin and CaMKII stabilise the structure of potentiated spines, we employed a chemical model of LTP that uses glycine to activate NMDARs to trigger spine head enlargement (<xref ref-type="bibr" rid="bib19">Fortin et al., 2010</xref>; <xref ref-type="bibr" rid="bib56">Shahi and Baudry, 1993</xref>). This is considered a relatively realistic chemical model for LTP (<xref ref-type="bibr" rid="bib19">Fortin et al., 2010</xref>) that mimics other features including an increase in mini excitatory postsynaptic current amplitude (<xref ref-type="bibr" rid="bib30">Lu et al., 2001</xref>) following stimulation. Anti-GFP immunofluorescence indicated that many mushroom-type spines had formed 4 hr after NMDAR activation, as expected (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, left panel). This was associated with a 3.7-fold increase (p=1.6 × 10<sup>–10</sup>) in puncta in neurons expressing WT α-actinin-2 (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). Bright puncta were localised to enlarged mushroom-type spines (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, arrows): 44±7% of mushroom-type spines contained PLA puncta in naïve neurons, rising to 82±3% after NMDAR activation (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). In comparison, lower proportions of thin (19±5% pre-activation; 31±5% post-activation) and stubby (10±2% pre; 35±5% post) spines exhibited PLA puncta. In sum, this data is consistent with a role for α-actinin-2-CaMKIIα interactions in stabilising the enlarged structure of potentiated spines.</p><p>Next, we compared PLA puncta formation in neurons expressing different fragments of α-actinin-2 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In line with evidence that α-actinin-2 EF hands mediate interactions with CaMKIIα (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>), expression of a construct limited to the EF hand motifs (‘EF1–4’) yielded similar results to those obtained with full-length α-actinin-2 with a puncta density of 0.41±0.04 per 10 µm dendrite rising to 1.01±0.06 (p=6.8 × 10<sup>–11</sup>) following NMDAR activation (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Deletion of the EF hands (‘∆EF1–4’) brought puncta density close to baseline levels irrespective of NMDAR activation with 0.18±0.04 and 0.21±0.03 puncta/10 µm dendrite before and after NDMAR activation, respectively (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Although PLA signal is a measure of protein proximity rather than direct protein-protein interaction, the low levels of puncta formation observed with the ∆EF1–4 construct indicate that puncta formation in this case is likely to correspond to direct interaction between CaMKII and α-actinin-2. The last four amino acids of α-actinin-2 (ESDL) are capable of binding to the PDZ domain of densin-180 (<xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>) in vitro, and cooperative interactions between the three proteins in ternary complexes have been put forward as potentially important for supporting the structure of dendritic spines (<xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>; <xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>). Expression of FLAG-α-actinin-2 lacking the last four amino acids (‘∆PDZ’) generated 0.46±0.06 PLA puncta per 10 µm in naïve synapses, rising to 0.88±0.08/10 µm (p=2.9 × 10<sup>–4</sup>) following NMDAR activation (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Similar responses were obtained with an EF hand construct lacking the PDZ motif (‘EF1–4∆PDZ’) with 0.30±0.03 puncta per 10 µm dendrite rising to 0.72±0.07/10 µm (p=1.1 × 10<sup>–5</sup>) following NMDAR activation (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Overall, we saw a mild attenuation of puncta formation when the PDZ motif was absent, most apparent in the context of the full-length protein following NMDAR activation (1.48-fold reduction in puncta density, p=0.0017). Nevertheless, our data indicate that the actinin EF hands are sufficient for robust α-actinin-2-CaMKII interactions, and this region underlies the marked elevation in interaction of the two proteins in enlarged spines.</p></sec><sec id="s2-2"><title>CaMKII-actinin interactions accumulate rapidly following NMDAR activation and are not affected by mutations that prevent regulatory phosphorylation</title><p>To understand how quickly CaMKII and α-actinin-2 associate following NMDAR activation, we fixed neurons expressing FLAG-α-actinin-2 at different times after the start of NMDAR activation then performed anti-FLAG/anti-CaMKIIα in situ PLA (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). PLA puncta accumulated rapidly reaching a plateau at 2 min following NMDAR activation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Fitting the time series data to a Hill function reveals that CaMKII-α-actinin-2 interactions – according to in situ PLA – reach 50% maximal levels after 22±1 s (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This rate of accumulation is consistent with a recently proposed hypothetical time-scale of CaMKII signalling in dendritic spines following the induction of LTP (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Time dependence and effect of phosphorylation site mutations on calmodulin-dependent protein kinase IIα (CaMKIIα)-α-actinin-2 association.</title><p>(<bold>A</bold>) Plot showing change in anti-FLAG-α-actinin-2/CaMKIIα proximity ligation assay (PLA) puncta density in neurons fixed a different times following NMDA receptor (NMDAR) activation. The data were fit to a Hill function with max = 0.80±0.01, n=1.4±0.1, and t<sub>50%</sub>=22±1 s. (<bold>B</bold>) Topology of CaMKIIα showing positions of three regulatory threonines in the context of the kinase domain (green), regulatory segment (blue), linker (light grey), and hub domain (dark grey). (<bold>C</bold>) Quantitation of PLA puncta per 10 μm dendrite before (black) and after (green) NMDAR activation in neurons expressing different combinations of FLAG-α-actinin-2 and V5-CaMKIIα variants. For panels (A) and (C), data are presented as the mean ± SE, and the number of neurons analysed for each condition is shown in parentheses. Neurons were imaged deriving from three independent cultures for each condition.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Full proximity ligation assay (PLA) datasets for time course experiments, and experiments with calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation site mutants.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Proximity ligation assay (PLA) imaging of calmodulin-dependent protein kinase IIα (CaMKIIα) association with α-actinin-2 PLA in neurons fixed at different time-points after NMDA receptor (NMDAR) activation.</title><p>Each panel shows anti-GFP immunofluorescence (left columns) and anti-CaMKIIα/anti-FLAG PLA puncta (middle columns) in primary hippocampal neurons transfected with GFP and FLAG-α-actinin-2. Neurons were fixed either before NMDAR activation (panel (A)) or at different time-points from the start of NMDAR activation (panels (B–F)), as indicated. Scale bars correspond to 20 μm (square panels) and 1 μm (dendrite close-ups).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Proximity ligation assay (PLA) imaging of α-actinin-2 association with wild-type and phospho-null variants of calmodulin-dependent protein kinase IIα (CaMKIIα).</title><p>Each panel shows anti-GFP immunofluorescence (left columns) and anti-V5/anti-FLAG PLA puncta (middle columns) in primary hippocampal neurons either before (top row) or after (bottom row) NMDA receptor (NMDAR) activation. All neurons expressed GFP. The first four panels correspond to imaging of neurons expressing FLAG-α-actinin-2 in combination with either wild-type (WT) (<bold>A</bold>), T286A (<bold>B</bold>), T305A (<bold>C</bold>), or T306A (<bold>D</bold>) variants of V5-CaMKIIα. The last two panels correspond to control imaging experiments performed in neurons transfected with one or the other of WT V5-CaMKIIα (<bold>E</bold>) or FLAG-α-actinin-2 (<bold>F</bold>). Scale bars correspond to 20 μm (square panels) and 1 μm (dendrite close-ups).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig2-figsupp2-v3.tif"/></fig></fig-group><p>CaMKII is subject to regulatory auto-phosphorylation at three sites (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Auto-phosphorylation at T286 supports autonomous low-level kinase activity (<xref ref-type="bibr" rid="bib2">Barcomb et al., 2014</xref>). This form of CaMKII regulation is thought to be important in the initial induction but not maintenance of LTP (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). The CaMKII regulatory segment is also subject to negative feedback auto-phosphorylation at T305 and T306, with phosphorylation at either site preventing further activation by CaM (<xref ref-type="bibr" rid="bib24">Hanson and Schulman, 1992</xref>; <xref ref-type="bibr" rid="bib42">Patton et al., 1990</xref>). pT306 but not pT305 phosphorylation has been shown to reduce α-actinin-2 binding to CaMKII in vitro (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). We investigated the effect of preventing phosphorylation at the three sites on interactions between CaMKIIα and α-actinin-2 using PLA. We first expressed N-terminally V5-tagged WT CaMKIIα in tandem with FLAG-α-actinin-2 in primary hippocampal neurons. Anti-V5/Anti-FLAG PLA puncta were detected at the expected levels with 0.38±0.02 puncta per 10 µm dendrite in naïve neurons rising to 1.23±0.02 after NMDAR activation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). PLA puncta remained at baseline levels irrespective of NMDAR activation if either construct was expressed in isolation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E and F</xref>). Puncta levels were little changed by alanine substitutions at either position 286 (0.40±0.01 puncta per 10 µm dendrite in naïve neurons rising to 1.17±0.01 after NMDAR activation, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>), position 305 (0.32±0.01 rising to 1.12±0.02, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>), or position 306 (0.44±0.01 rising to 1.24±0.02, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>). The absence of any marked effect when substituting T286A indicates that CaMKIIα auto-phosphorylation at T286 is not required for baseline or elevated association between CaMKIIα and α-actinin-2 in our system. It should be noted that T286 auto-phosphorylation is thought to be particularly important in the initial induction phase of LTP following summation of multiple Ca<sup>2+</sup> transients (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>), which is not a function that would be required using our chemical LTP protocol. The absence of substantial changes compared to WT in either the T305A and T306A variants of CaMKIIα (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) suggests that phosphorylation at either site does not play a significant role in regulating CaMKIIα-α-actinin-2 interactions. Overall, our data indicate that CaMKIIα-α-actinin-2 interactions increase within the first 2 min of LTP induction, and CaMKII phosphorylation is not essential for regulating interaction between the two proteins.</p></sec><sec id="s2-3"><title>Disruption of CaMKII-actinin interaction prevents spine enlargement following NMDAR activation</title><p>We noticed during PLA imaging that dendrites of neurons expressing α-actinin-2 EF1–4 seemed to exhibit fewer mushroom-type spines following NMDAR activation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) than those expressing either GFP alone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) or the full-length α-actinin-2 construct (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The α-actinin-2 EF1–4 construct (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) lacks elements including the actin-binding domain and therefore can be expected to operate as a disruptor of actinin-mediated linking of CaMKII to the actin cytoskeleton. Furthermore, the only known interaction partner for the EF1–4 region of α-actinin-2 besides CaMKII is the muscle-specific protein titin (<xref ref-type="bibr" rid="bib72">Young et al., 1998</xref>), so any effects of EF1–4 in neurons are likely to reflect destabilisation of native interactions between CaMKII and α-actinin-2. To investigate this disruptor effect further, we compared numbers of stubby (red), thin (amber), and mature mushroom-type (green) spines in neurons expressing either GFP alone (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), GFP with α-actinin-2 EF1–4 WT (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), or GFP with α-actinin-2 EF1–4 L854R (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The L854R mutation falls within the fourth EF hand and disrupts α-actinin-2 binding to the CaMKII regulatory segment (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>) thus serves as a negative control. PLA imaging confirmed that association with CaMKII was greatly reduced for the L854R variant (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Prior to NMDAR activation, the total number of spines was approximately one-third lower in neurons expressing the WT EF1–4 construct than in the other two conditions (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). For all three conditions, the distribution of spine types was initially similar (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), with stubby spines predominating at ~1.5 stubby spines per 10 µm dendrite prior to NMDAR activation. However, whereas NMDAR activation triggered a transition from stubby to mushroom-type spines in neurons expressing GFP alone (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) or GFP/EF1–4 L854R (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), no such transformation occurred in neurons expressing the WT EF1–4 disruptor (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Effect of EF hand disruptors on changes in spine morphology following NMDA receptor (NMDAR) activation.</title><p>Panels (<bold>A</bold>–<bold>C</bold>) show GFP imaging of primary hippocampal neurons transfected with either GFP alone (<bold>A</bold>), or GFP in combination with α-actinin-2 EF1–4 wild-type (WT) (<bold>B</bold>) or L854R (<bold>C</bold>). For (<bold>A</bold>–<bold>C</bold>), the upper rows show imaging of naïve synapses, and the lower rows show imaging 4 hr after NMDAR activation. Stubby (red), thin (orange), and mushroom (green) type synapses are highlighted with arrows. Scale bars correspond to 20 μm (whole neuron images) and 1 μm (dendrite close-ups). Panels (D–F) show quantification of spine types across the three conditions either before NMDAR activation (<bold>D</bold>), 1 hr after NMDAR activation (<bold>E</bold>), or 4 hr after activation (<bold>F</bold>). Data are presented as mean ± SE spines per 10 μm dendritic length. The number of neurons analysed for each condition is shown in parentheses. Neurons were imaged deriving from three independent cultures for each condition. Red, orange, and green bars indicate stubby, thin, and mushroom spine numbers, respectively. In panels E and F, statistical comparisons were performed using unpaired two-tailed Student’s t-tests (***p &lt; 0.001).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Full spine classification dataset.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Proximity ligation assay (PLA) imaging of calmodulin-dependent protein kinase IIα (CaMKIIα) association with α-actinin-2 EF1–4 disruptors.</title><p>The first two panels show imaging following transfections with GFP in combination with either wild-type (WT) (<bold>A</bold>) or L854R (<bold>B</bold>) α-actinin-2 EF1–4. Each panel shows anti-GFP immunofluorescence (left columns) and anti-CaMKIIα/anti-FLAG PLA puncta (middle columns) in primary hippocampal neurons either before (upper row) or after (lower row) NMDA receptor (NMDAR) activation. Scale bars correspond to 20 μm (whole neuron images) and 1 μm (dendrite close-ups). (<bold>C</bold>) Quantitation of dendritic PLA puncta density before (black) and after (green) NMDAR activation. Data are normalised to EF1–4 WT post NMDAR activation. The number of neurons analysed for each construct is shown in parentheses. PLA puncta density was reduced by 80% pre-activation (p=2.4 × 10<sup>–7</sup>) and 83% post NMDAR activation (p=2.0 × 10<sup>–7</sup>) in neurons expressing EF1–4 L854R compared to the WT variant.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Full proximity ligation assay (PLA) dataset for comparison of wild-type (WT) and L854R disruptor variants.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig3-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig3-figsupp1-v3.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Effect of EF hand disruptors on total spine density and average spine diameter.</title><p>(<bold>A</bold>) Total spine density in primary hippocampal neurons transfected with either GFP alone or GFP in combination with either wild-type (WT) or L854R α-actinin-2 EF1–4. Mean spine number ± SE per 10 µm dendrite is shown before NMDA receptor (NMDAR) activation (black), and 1 hr (orange) and 4 hr (green) after activation. Numbers of neurons analysed for each condition are shown in parentheses. Before NMDAR activation, neurons expressing EF1–4 WT had 32% fewer spines than those expressing GFP alone (p=0.0013); and 34% fewer total spines than those expressing the L854R variant (p=5.33 × 10<sup>–5</sup>). (<bold>B</bold>) Changes in spine diameter (mean ± SE) are shown either 1 (orange) or 4 (green) hr after NMDAR activation.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Full dataset for total spine number and changes in spine diameter for disruptor experiments.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig3-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig3-figsupp2-v3.tif"/></fig></fig-group><p>Four hours after NMDAR activation (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), stubby spines had decreased in abundance from 1.50±0.19 to 0.67±0.10/10 µm in GFP-only neurons (p=0.0013), and from 1.64±0.15 to 0.65±0.10/10 µm in neurons expressing L854R EF1–4 (p=7.2 × 10<sup>–6</sup>). Furthermore, mushroom spines accounted for approximately half of all spines 4 hr after NMDAR activation (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). In contrast, mushroom spines did not accumulate in neurons expressing WT EF1–4 disruptor, such that after 4 hr there were 7.2-fold fewer mushroom spines in these neurons than in GFP control neurons (p=3.43 × 10<sup>–11</sup>) and 6.8-fold fewer than in L854R EF1–4 neurons (p=4.81 × 10<sup>–6</sup>). The number of stubby spines also remained unchanged in WT EF1–4 neurons (1.24±0.16 before vs 1.22±0.18/10 µm 4 hr after NDMAR activation). The lack of plasticity in neurons expressing the WT EF1–4 disruptor was also reflected in analysis of changes in the average spine diameter upon NMDAR activation (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). Mean spine diameter increased by 58.3% (p=7.1 × 10<sup>–8</sup>) and 65.5% (p=1.3 × 10<sup>–4</sup>) over 4 hr in GFP-only and L854R EF1–4 neurons, respectively, whereas expression of the WT EF1–4 disruptor limited the increase to only 11% (p=0.17). These results build on previous reports that siRNA-mediated knockdown of α-actinin-2 reduces mushroom-type spine formation following NMDAR activation (<xref ref-type="bibr" rid="bib26">Hodges et al., 2014</xref>) by resolving a key role for the interface with CaMKII in this process. In sum, our PLA and spine imaging data indicate that α-actinin-2-CaMKII interactions accumulate upon induction of structural LTP via NMDAR activation, and that interaction between the two is necessary to support the formation of enlarged mushroom-type spines.</p></sec><sec id="s2-4"><title>The CaMKII kinase domain decreases affinity of α-actinin-2 for the regulatory segment</title><p>Previous studies have shown that EF hands 3 and 4 of α-actinin-2 (hereafter referred to as ‘EF3–4’) are sufficient for binding CaMKIIα via its regulatory segment (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>). Ca<sup>2+</sup>/CaM binds to CaMKII by employing its four EF hands to wrap around the regulatory segment. Since the segment is partially buried against the kinase domain in the inactive kinase (<xref ref-type="bibr" rid="bib9">Chao et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>), Ca<sup>2+</sup>/CaM binds much more tightly to isolated regulatory segment than to constructs that include the kinase domain (<xref ref-type="bibr" rid="bib18">Forest et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>). This is significant since factors that alter the accessibility of the regulatory segment, including T286 auto-phosphorylation (<xref ref-type="bibr" rid="bib58">Singla et al., 2001</xref>) and association with NMDARs (<xref ref-type="bibr" rid="bib4">Bayer et al., 2001</xref>), can trap CaM. For α-actinin-2, the assumption has been that EF3–4 is able to fully access the regulatory segment in inactive CaMKII since only two EF hands are involved in the interaction (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). However, our PLA data suggest that a mechanism exists for increasing CaMKIIα-actinin interactions following induction of LTP (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). We therefore employed ITC using purified proteins (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) to determine whether the kinase domain impedes access of α-actinin-2 to the regulatory segment in inactive CaMKII. We compared binding to a peptide corresponding to the regulatory segment (positions 294–315), and to a longer construct (1–315) that includes the kinase domain. An N-terminal thioredoxin (Trx) tag was fused at the N-terminus of the longer construct – where it would not be expected to affect interactions with the regulatory segment (<xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>) – to ensure that the protein remained soluble at high concentrations necessary for ITC (<xref ref-type="bibr" rid="bib12">Costa et al., 2014</xref>). EF3–4 bound to the regulatory segment peptide (294–315) with a dissociation constant (K<sub>d</sub>)=32±1 µM (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). In contrast, it was not possible to determine a K<sub>d</sub> for binding to the longer construct (1–315), with heat changes indistinguishable from background indicative of weaker binding (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Control experiments using CaM confirmed that, as expected, CaM binds more tightly to isolated regulatory segment (K<sub>d</sub> = 11±1 nM, <xref ref-type="fig" rid="fig4">Figure 4C</xref>) than to Trx-CaMKIIα 1–315 (K<sub>d</sub> = 2.8±0.2 µM, <xref ref-type="fig" rid="fig4">Figure 4D</xref>), consistent with previous studies (<xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Isothermal titration calorimetry of interactions with the calmodulin-dependent protein kinase IIα (CaMKIIα) regulatory segment.</title><p>Representative isotherms showing binding of α-actinin-2 EF3–4 to (<bold>A</bold>) peptide corresponding to CaMKII⍺ regulatory segment (294–315) and (<bold>B</bold>) a construct (1–315) corresponding to the kinase and regulatory segment regions of CaMKIIα. Binding of CaM and α-actinin-2 EF1–4 to the same two CaMKII regions are shown in panels (<bold>C</bold>) and (<bold>D</bold>) and (<bold>E</bold>) and (<bold>F</bold>), respectively. In all cases, the top sub-panels show the raw power output (µcal/s) per unit time; the bottom sub-panels show the integrated data including a line of best fit to a single site binding model. Stated K<sub>d</sub> values are averages from experimental replicates. ND = not determined.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Full isothermal titration calorimetry (ITC) dataset.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig4-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Purified proteins.</title><p>Coomassie-stained 4–12% polyacrylamide gels are shown for purified EF1–4/EF3–4 fragments of α-actinin-2 (<bold>A</bold>), Trx-CaMKIIα 1–315 (<bold>B</bold>), CaM (<bold>C</bold>), full-length CaMKIIα (<bold>D</bold>), and GluN2B 1260–1492 (<bold>E</bold>).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Uncropped Coomassie-stained gels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-85008-fig4-figsupp1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Raw image for panels (A–D).</title></caption><media mimetype="image" mime-subtype="jpeg" xlink:href="elife-85008-fig4-figsupp1-data2-v3.jpg"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Raw image for panel (E).</title></caption><media mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig4-figsupp1-data3-v3.tif"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig4-figsupp1-v3.tif"/></fig></fig-group><p>We next examined the notion that the first two EF hands of α-actinin-2 do not contribute to binding to the CaMKII regulatory segment (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>). Purified EF1–4 bound to the isolated regulatory segment (294–315) with K<sub>d</sub> = 11±0.2 µM (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) – a threefold lower concentration than EF3–4 alone (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This is similar to K<sub>d</sub> = ~4 μM recorded for association of EF1–4 with peptide corresponding to titin Z repeat 7 (<xref ref-type="bibr" rid="bib21">Grison et al., 2017</xref>). Like the shorter actinin construct (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), no binding was detected between EF1–4 and Trx-CaMKIIα (1–315) (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Overall, our measurements show that – like CaM – α-actinin-2 is unable to fully access the CaMKII regulatory segment in the autoinhibited enzyme. Furthermore, our data reveal that when the regulatory segment is fully accessible, all four EF hands of α-actinin-2 are required for the highest affinity binding. Full thermodynamic parameters obtained for all ITC measurements are shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Thermodynamic parameters for interactions between α-actinin-2 and calmodulin-dependent protein kinase IIα (CaMKIIα) constructs.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Cell</th><th align="left" valign="bottom">Syringe</th><th align="left" valign="bottom">Reps</th><th align="left" valign="bottom">N</th><th align="left" valign="bottom">K<sub>d</sub> (μM)</th><th align="left" valign="bottom">ΔH (kcal/mol)</th><th align="left" valign="bottom">–TΔS (kcal/mol)</th></tr></thead><tbody><tr><td align="left" valign="bottom">EF3–4</td><td align="left" valign="bottom">CaMKIIα 294–315</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">0.98±0.04</td><td align="left" valign="bottom">32±0.9</td><td align="left" valign="bottom">–6.7±0.06</td><td align="left" valign="bottom">0.61±0.06</td></tr><tr><td align="left" valign="bottom">CaMKIIα 1–315</td><td align="left" valign="bottom">EF3–4</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td></tr><tr><td align="left" valign="bottom">EF1–4</td><td align="left" valign="bottom">CaMKIIα 294–315</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">0.98±0.01</td><td align="left" valign="bottom">11±0.2</td><td align="left" valign="bottom">–3.0±0.005</td><td align="left" valign="bottom">–3.7±0.01</td></tr><tr><td align="left" valign="bottom">CaMKIIα 1–315</td><td align="left" valign="bottom">α-Actinin-2 EF1–4</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td><td align="left" valign="bottom">ND</td></tr><tr><td align="left" valign="bottom">CaM</td><td align="left" valign="bottom">CaMKIIα 294–315</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">0.99±0.03</td><td align="left" valign="bottom">0.011±0.0007</td><td align="left" valign="bottom">4.3±0.2</td><td align="left" valign="bottom">–14.6±0.2</td></tr><tr><td align="left" valign="bottom">CaMKIIα 1–315</td><td align="left" valign="bottom">CaM</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">1.06±0.02</td><td align="left" valign="bottom">2.8±0.2</td><td align="left" valign="bottom">11.3±0.1</td><td align="left" valign="bottom">–18.5±0.07</td></tr><tr><td align="left" valign="bottom">EF3–4</td><td align="left" valign="bottom">CaMKIIα 299–315</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">0.66±0.02</td><td align="left" valign="bottom">17.8±1.5</td><td align="left" valign="bottom">–11±0.5</td><td align="left" valign="bottom">4.7±0.6</td></tr><tr><td align="left" valign="bottom">CaM</td><td align="left" valign="bottom">CaMKIIα 299–315</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">1±0.01</td><td align="left" valign="bottom">0.047±0.001</td><td align="left" valign="bottom">4.51±0.04</td><td align="left" valign="bottom">–14±0.05</td></tr></tbody></table></table-wrap></sec><sec id="s2-5"><title>Structure of the core α-actinin-2-CaMKII interface</title><p>Previous structural models of α-actinin-2-CaMKII interaction have assumed that the third and fourth EF hands of α-actinin-2 bind to the CaMKII regulatory segment in a similar mode to the third and fourth EF hands of Ca<sup>2+</sup>/calmodulin (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>) in such a way that α-actinin-2 could fully access the regulatory segment in the inhibited kinase (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). However, our ITC measurements indicate that α-actinin-2 access to the regulatory segment is impeded in autoinhibited CaMKIIα (<xref ref-type="table" rid="table1">Table 1</xref>). Furthermore, PLA assays show increased association of the two proteins following chemical LTP protocols that activate CaMKII (<xref ref-type="fig" rid="fig1">Figure 1</xref>). To establish a structural basis for these findings, we crystallised α-actinin-2 EF3–4 in complex with a peptide corresponding to the CaMKIIα regulatory segment (positions 294–315). We solved the crystal structure at 1.28 Å resolution (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>) using X-ray diffraction with phasing through single-wavelength anomalous diffraction of native sulfur atoms (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The asymmetric unit contains two copies of the complex (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>) – the two copies are highly similar (RMSD 0.202 Å for all atoms, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Our analysis focuses on the first copy of the complex (chains A and B in PDB ID 6TS3) for which it was possible to position the full EF3–4 region (824–894) and positions 294–313 of the CaMKIIα regulatory segment in electron density.</p><p>In the complex, the CaMKII regulatory segment (blue, <xref ref-type="fig" rid="fig5">Figure 5A</xref>) forms an amphipathic helix with four hydrophobic residues (L299, I303, M307, F313) aligned and engaged in van der Waals interactions with α-actinin-2 EF3–4 (orange, <xref ref-type="fig" rid="fig5">Figure 5A</xref>). M307<sub>CaMKII</sub> is buried closest to the centre of the EF3–4 domain, where it contacts the sidechains of EF3–4 residues F835 and L854. This binding mode is consistent with the reduction in PLA puncta that we observed with the EF3–4 mutation L854R (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) and with earlier pull-down experiments (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). α-Actinin-2 mutations S834R or Y861R have also been found to prevent association with CaMKII (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>), and both of these residues also directly contact the regulatory segment in the crystal structure. The most N-terminal amino acid in the regulatory segment to engage directly with EF3–4 is L299<sub>CaMKII</sub>, which interacts with Y861<sub>EF3-4</sub> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>): unexpectedly, positions 294–298 are solvent exposed. At the other end of the regulatory segment, the benzene ring of F313<sub>CaMKII</sub> packs against the sidechain of I837<sub>EF3-4</sub> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Deletion studies have found that the last nine amino acids (886–894) of α-actinin-2 are necessary for binding CaMKII (<xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>). This region includes Y889<sub>EF3-4</sub>, which engages in van der Waals interactions with L304<sub>CaMKII</sub> through its benzene ring and H-bonds with the backbone oxygen of K300<sub>CaMKII</sub>. The last four amino acids of α-actinin-2 (‘ESDL’) form a potential ligand for PDZ domains in proteins including densin-180 (<xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>; <xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>). In the structure, G890<sub>EF3-4</sub> reorients the polypeptide chain away from the interface with CaMKII such that this PDZ ligand is accessible (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Mutational analyses have previously shown that phosphorylation at T306 but not T305 reduces binding to α-actinin-2 (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). This tallies with the crystal structure, in which T305 projects away from the interface with EF3–4 whereas the hydroxyl group of T306 engages in a H-bond network that includes Gln858<sub>EF3-4</sub>, and its Cγ atom is packed against P885<sub>EF3-4</sub> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). In comparison, both T305 and T306 are buried in complex with CaM (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). The EF3–4 region adopts a similar conformation in complex with the CaMKII regulatory segment as in the crystal structure of full-length apo α-actinin-2 (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>) with 1.168 Å RMSD for all atoms. The CaMKIIα regulatory segment (blue, <xref ref-type="fig" rid="fig5">Figure 5C</xref>) occupies the same position as the neck region of α-actinin-2 (grey, <xref ref-type="fig" rid="fig5">Figure 5C</xref>). In neurons, association of the actin-binding domain of α-actinin-2 with actin filaments, and binding of PIP<sub>2</sub> phospholipids in the vicinity of the neck region, are thought to ensure that EF3–4 is available for interaction with CaMKII (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>; <xref ref-type="bibr" rid="bib25">Hell, 2014</xref>). The neck region residue Ile269 occupies the equivalent position to Met307<sub>CaMKII</sub> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), although the polypeptides run in opposite directions across the EF3–4 region.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Structure of the core α-actinin-2-calmodulin-dependent protein kinase IIα (CaMKIIα) interface.</title><p>Panels (<bold>A</bold>) and (<bold>B</bold>) show two views of the complex between α-actinin-2 EF3–4 (orange) and a peptide corresponding to the CaMKIIα regulatory segment (blue). The C-terminal tetrapeptide that is a ligand for PDZ domain-containing proteins including densin-180 is highlighted. (<bold>C</bold>) Comparison of α-actinin-2-EF3–4 domain association with the neck region (grey) in α-actinin-2 dimers (1H8B) and the CaMKII regulatory segment (6TS3). The structures were aligned through the EF3–4 domain. Panels (<bold>D</bold>) and (<bold>E</bold>) show two views comparing CaM (<bold>D</bold>) and α-actinin-2 EF3–4 (<bold>E</bold>) association with the CaMKIIα regulatory segment. The structures were aligned through the regulatory segment. For the CaM complex (2WEL), the N-lobe is coloured dark purple; the C-lobe is violet.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Additional features of the ⍺-actinin-2 EF3–4-calmodulin-dependent protein kinase IIα (CaMKIIα) regulatory segment crystal structure.</title><p>(<bold>A</bold>) 2F<sub>o</sub>-F<sub>c</sub> electron density map contoured at 1.5σ and clipped within 1.5 Å of the polypeptides (chains <bold>A</bold> and <bold>C</bold>). (<bold>B</bold>) Asymmetric unit showing two copies of the EF3–4-CaMKIIα regulatory segment complex related to each other by a twofold rotational symmetry axis. (<bold>C</bold>) Superimposition of the two copies of the complex. The first copy (chains <bold>A</bold> and <bold>C</bold>) is shown in magenta; the second copy (chains <bold>B</bold> and <bold>D</bold>) in dark blue. The two copies align with RMSD = 0.202 Å for all atoms encompassing α-actinin-2 822–891 and CaMKIIα 294–310. Panels (<bold>D</bold>) and (<bold>E</bold>) show close-ups highlighting the positions of CaMKIIα threonines 305 and 306 in complex with either EF3–4 complex (<bold>D</bold>) or CaM (<bold>E</bold>). (<bold>F</bold>) Aligned Cα conformations of the CaMKIIα regulatory segment in complex with either EF3–4 (light blue) or CaM (dark blue).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig5-figsupp1-v3.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Calorimetry with calmodulin-dependent protein kinase IIα (CaMKIIα) 299–315 peptide.</title><p>Representative isotherms are shown for titrations of the peptide with (<bold>A</bold>) α-actinin-2 EF3–4 and (<bold>B</bold>) CaM. The top sub-panels show the raw power output (µcal/s) per unit time; the bottom sub-panels show the integrated data including a line of best fit to a single site binding model. Stated K<sub>d</sub> values are averages from three replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig5-figsupp2-v3.tif"/></fig></fig-group><p>Previous modelling of the CaMKII-actinin interaction has been built on the assumption that α-actinin-2 EF3–4 binds to CaMKII using the same binding mode as the CaM C-lobe (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>). However, comparison to the crystal structure of CaMKIIδ (11–315) in complex with Ca<sup>2+</sup>/CaM (<xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>) shows that the binding modes are distinct. Ca<sup>2+</sup>/CaM fully encompasses the regulatory segment (whose sequence is identical between the α and δ isoforms) with the C-lobe (violet, <xref ref-type="fig" rid="fig5">Figure 5D</xref>) mediating most interactions to the hydrophobic face of the helix. The N-lobe (deep purple) is responsible for the bulk of H-bonding to the helical side that is solvent exposed in complex with α-actinin-2 EF3–4 (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). The centre of mass of EF3–4 is rotated by ~50° relative to the CaM C-lobe when viewed along the central axis of the regulatory segment (lower panels, <xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). In addition, the CaM C-lobe engages the regulatory segment approximately one helical turn further to its N-terminus than α-actinin-2 EF3–4, including interactions with positions A295 and K298. The conformation of the regulatory segment itself also differs between the two complexes. In complex with α-actinin-2 EF3–4, the helical structure breaks down at the C-terminal end to reorient F313 for interaction with I837<sub>EF3-4</sub> (light blue, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). In complex with Ca<sup>2+</sup>/CaM, alpha-helicity is maintained for the full length of the regulatory segment, which directs F313 in the opposite direction for interaction with the CaM N-lobe (dark blue, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). Since CaMKIIα positions 294–298 are solvent exposed in the complex with α-actinin-2 EF3–4 but not CaM, we performed further ITC measurements with a truncated regulatory segment peptide (299–315) to corroborate the binding mode observed in the crystal structure. α-Actinin-2 EF3–4 bound CaMKIIα 299–315 peptide with K<sub>d</sub> = 17.8±1.5 μM (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>) – comparable to its affinity for CaMKIIα 294–315 (K<sub>d</sub> = 32±1). Consistent with the crystal structures, CaM associated with CaMKIIα (299–315) with K<sub>d</sub> = 47±1 nM (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>) – approximately fivefold higher than for the longer peptide (K<sub>d</sub> = 11 ± 1 nM). This also tallies with previous reports that positions 293–295 in the regulatory segment mediate interactions with CaM that markedly reduce the off-rate (<xref ref-type="bibr" rid="bib45">Putkey and Waxham, 1996</xref>; <xref ref-type="bibr" rid="bib67">Waxham et al., 1998</xref>). Overall, our structural data show how α-actinin-2 employs a unique binding mode to interact with the CaMKII regulatory segment.</p></sec><sec id="s2-6"><title>Occlusion of the regulatory segment to α-actinin-2 can be released by association with GluN2B</title><p>The reduced affinity of EF3–4/EF1–4 for the CaMKII regulatory segment in constructs that include the kinase domain (<xref ref-type="table" rid="table1">Table 1</xref>) suggests that the kinase domain impedes α-actinin-2 access to the regulatory segment. To understand the structural basis of this effect, we superimposed the EF3–4-regulatory segment complex structure on previously determined crystal structures of autoinhibited CaMKII. <xref ref-type="fig" rid="fig6">Figure 6A and B</xref> shows superimposition onto the structure of CaMKIIα (13–302) bound to the inhibitor indirubin (<xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>). In this structure L299 is the last visible residue in CaMKII (<xref ref-type="bibr" rid="bib47">Rellos et al., 2010</xref>). The common residues 294–299 align closely with RMSD = 0.2 Å for backbone carbon and oxygen atoms (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). The superimposition shows that – without reorientation or partial release of the regulatory segment from the kinase domain – both termini of the EF3–4 region will clash with the kinase domain (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). Steric incompatibility of the kinase domain and EF3–4 region is most evident in the vicinity of the kinase domain αG helix (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), which is located in the equivalent position to the last five amino acids of α-actinin-2. We also superimposed the EF3–4-regulatory segment complex onto the crystal structure of a chimeric form of full-length CaMKII, which incorporates WT sequence for CaMKIIα up to position T305 (<xref ref-type="bibr" rid="bib9">Chao et al., 2011</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B and C</xref>). The two structures were aligned on the basis of the common positions 294–305. In this case, steric clashing was more pronounced since the regulatory segment kinks towards the kinase domain in this case (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Effect of GluN2B on access to the regulatory segment.</title><p>Panels (<bold>A</bold>) and (<bold>B</bold>) show two views of the superimposition of the α-actinin-2-regulatory segment complex (6TS3) over the structure of calmodulin-dependent protein kinase IIα (CaMKIIα) 1–299 (2VZ6). The structures were aligned using positions 294–299 of the regulatory segment. Regions of steric incompatibility between the kinase (green) and EF3–4 domain (orange) are highlighted. Panel (C) shows a close-up highlighting steric clashing in the vicinity of the CaMKIIαG helix. (<bold>D</bold>) Pull-down of purified CaMKIIα with magnetic beads charged with either GST or GST-EF1–4. CaMKII pull-down was compared ± GluN2Bc fragment, and at different final free Ca<sup>2+</sup> concentrations, as indicated. CaMKIIα and GST/GST-EF14 were detected by anti-CaMKIIα (upper) and anti-GST (lower) immunoblots (IBs). (<bold>E</bold>) Densitometry for pull-down experiments shown in the preceding panel showing CaMKII recovery at each free Ca<sup>2+</sup> concentration either with (gold) or without (black) GluN2Bc (n=3 for all conditions). Statistical comparisons were performed using unpaired two-tailed Student’s t-tests (*p &lt; 0.05, ***p &lt; 0.001). (<bold>F</bold>) Domain topology of GluN2B showing the location of the internal HA tag and CaMKII binding site within the C-terminal tail (gold). (<bold>G</bold>) Quantitation of anti-HA/anti-CaMKII proximity ligation assay (PLA) puncta per 10 μm dendrite before (black) and after (green) NMDA receptor (NMDAR) activation in neurons expressing GluN2B-iHA variants as indicated. (<bold>H</bold>) Quantitation of anti-HA/anti-FLAG PLA puncta per 10 μm dendrite before (black) and after (green) NMDAR activation in neurons expressing combinations of GluN2B-iHA variants and FLAG-α-actinin-2 as indicated. For panels (G) and (H), data are presented as the mean ± SE, and the number of neurons analysed for each condition is shown in parentheses. Neurons were imaged deriving from three independent cultures for each condition.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Densitometry breakdown for calmodulin-dependent protein kinase II (CaMKII) pull-down experiments and full proximity ligation assay (PLA) dataset for experiments investigating interactions with GluN2B.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85008-fig6-data1-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Uncropped immunoblots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85008-fig6-data2-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Raw image for anti-calmodulin-dependent protein kinase II (anti-CaMKII) immunoblot.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85008-fig6-data3-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Raw image for anti-GST immunoblot.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85008-fig6-data4-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Modelling relative orientations of kinase and EF3–4 domains relative to the regulatory segment.</title><p>(<bold>A</bold>) Alignment of all atoms for calmodulin-dependent protein kinase IIα (CaMKIIα) positions 294–299 in crystal structures 2VZ6 and 6TS3. Cα atoms are shown as spheres. Panels (<bold>B</bold>) and (<bold>C</bold>) show two views of the superimposition of the α-actinin-2-regulatory segment complex (6TS3) onto the structure of CaMKIIα (3SOA-β7 linker and hub domain are not shown). The structures were aligned through positions 294–305 of the regulatory segment.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Proximity ligation assay (PLA) imaging of calmodulin-dependent protein kinase IIα (CaMKIIα) association with variants of GluN2B.</title><p>Each panel shows anti-GFP immunofluorescence (left columns) and anti-CaMKIIα/anti-HA PLA puncta (middle columns) in primary hippocampal neurons either before (top row) or after (bottom row) NMDA receptor (NMDAR) activation. The images correspond to neurons transfected with wild-type (WT) GluN2B-iHA (<bold>A</bold>), GluN2B-iHA ∆CaMKII (<bold>B</bold>), or GFP only (<bold>C</bold>). Scale bars correspond to 20 μm (square panels) and 1 μm (dendrite close-ups).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig6-figsupp2-v3.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Proximity ligation assay (PLA) imaging of α-actinin-2 association with GluN2B variants.</title><p>Each panel shows anti-GFP immunofluorescence (left columns) and anti-FLAG/anti-HA PLA puncta (middle columns) in primary hippocampal neurons either before (top row) or after (bottom row) NMDA receptor (NMDAR) activation. All neurons expressed GFP. The panels correspond to neurons additionally expressing GluN2B-iHA wild-type (WT) and FLAG-α-actinin-2 (<bold>A</bold>), GluN2B-iHA ∆CaMKII and FLAG-α-actinin-2 (<bold>B</bold>), GluN2B-iHA WT only (<bold>C</bold>), and FLAG-α-actinin-2 only (<bold>D</bold>). Scale bars correspond to 20 μm (square panels) and 1 μm (dendrite close-ups).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig6-figsupp3-v3.tif"/></fig></fig-group><p>We found that α-actinin-2 association with CaMKII was markedly increased in dendritic spines 4 hr after chemical induction of LTP by NMDAR activation (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Since our structural and calorimetry data show that the kinase domain occludes α-actinin-2 access to the regulatory segment in autoinhibited CaMKII, the mechanism underlying this increase in association is likely to involve regulatory segment release. Existing knowledge of CaMKII regulation during LTP suggests two possibilities: auto-phosphorylation at T286 and formation of NMDAR-CaMKII complexes (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). During the initial phase of LTP induction, CaMKII auto-phosphorylates at T286 to generate an autonomously active form with partial activity of ~20% (<xref ref-type="bibr" rid="bib2">Barcomb et al., 2014</xref>). The pT286 modification is likely to partially disengage the regulatory segment from the kinase domain, however this modification does not endure for more than ~10 s following the induction of LTP (<xref ref-type="bibr" rid="bib8">Chang et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). Furthermore, we show that CaMKIIα-α-actinin-2 interactions are not affected by the mutation T286A either before or after chemical LTP (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). A more logical possibility to explain increased actinin-CaMKII association hours after LTP induction is the formation of NMDAR-CaMKII complexes that endure hours following CaMKII activation (<xref ref-type="bibr" rid="bib4">Bayer et al., 2001</xref>; <xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). CaMKII binds tightly to a site centred on S1303 in the GluN2B C-terminal tail (<xref ref-type="bibr" rid="bib38">Omkumar et al., 1996</xref>; <xref ref-type="bibr" rid="bib61">Strack et al., 2000a</xref>), and recent crystallographic work shows how this sequence wraps around the kinase domain using a binding mode that necessitates full displacement of the regulatory segment from the kinase domain (<xref ref-type="bibr" rid="bib40">Özden et al., 2022</xref>). To investigate the possibility that GluN2B supports CaMKIIα binding to α-actinin-2, we compared pull-down of full-length CaMKIIα with magnetic glutathione beads charged with either GST or GST-EF1–4 and determined the effect of including a purified fragment of the GluN2B tail spanning positions 1260–1492 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>) – hereafter referred to as ‘GluN2Bc’. In all cases, an initial pre-incubation step was included to enable CaMKII-GluN2B association (0.1 μM CaMKIIα, 3 μM CaM, 1.5 μM GluN2Bc incubated for 1 hr in buffer including 2 mM CaCl<sub>2</sub> and 0.5 mM ADP) prior to addition of EGTA and incubation with the charged magnetic beads. Reaction mixtures were supplemented with 2% BSA, and incubated with the magnetic beads for only 20 min to reduce basal pull-down in the absence of GluN2Bc. We also compared CaMKII pull-down with three final EGTA concentrations: 10, 2.5, or 1.8 mM corresponding to final approximate free Ca<sup>2+</sup> concentrations of 15 nM, 0.4 μM, and 200 μM (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). CaMKII recovery without GluN2B was reduced from 2.5 ± 0.8% to 0 ± 0.1% (p=0.027, <xref ref-type="fig" rid="fig6">Figure 6E</xref>) in the absence of GluN2B moving from low to high final Ca<sup>2+</sup> (lanes 5 and 13, <xref ref-type="fig" rid="fig6">Figure 6D</xref>), consistent with previous reports that Ca<sup>2+</sup>/CaM alone outcompetes α-actinin-2 for binding to CaMKII (<xref ref-type="bibr" rid="bib49">Robison et al., 2005a</xref>). Some association without GluN2Bc at low Ca<sup>2+</sup> levels is consistent with our PLA imaging (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) and with the original identification of the actinin-CaMKII interaction by the yeast two-hybrid method (; <xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>) and it should be noted that this baseline interaction is more pronounced under less stringent binding conditions (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>).</p><p>Addition of GluN2Bc led to striking increases in CaMKII recovery irrespective of EGTA concentration. At ~15 nM free Ca<sup>2+</sup>, GluN2Bc increased recovery from 2.5±0.8% to 33 ± 0.5% (lanes 5 and 6, <xref ref-type="fig" rid="fig6">Figure 6B</xref>, p=5.0 × 10<sup>–6</sup>). At 0.4 μM Ca<sup>2+</sup>, recovery increased from 1.7±0.3% to 31 ± 11% (lanes 9 and 10, p=0.055). Surprisingly, the effect was maintained at 200 μM free Ca<sup>2+</sup>, with GluN2Bc increasing recovery from 0 ± 0.1% to 40 ± 13% (lanes 13 and 14, <xref ref-type="fig" rid="fig6">Figure 6D</xref>, p=0.032). The effects of GluN2Bc on CaMKII recovery are summarised in <xref ref-type="fig" rid="fig6">Figure 6E</xref>. Overall, these experiments indicate that association of CaMKII with GluN2B subunits following LTP is a plausible mechanism to enable increased interaction between the kinase and α-actinin-2 in structural LTP. We next aimed to test this notion using in situ PLA measurements with GluN2B subunits. To this end, we modified a vector that expresses GFP-GluN2B by inserting an internal HA tag between positions G1211 and G1212 (‘GluN2B-iHA’, <xref ref-type="fig" rid="fig6">Figure 6F</xref>) We also generated a CaMKII binding-deficient variant of GluN2B-iHA (‘ΔCaMKII’) by introducing the double mutation L1298A/R1300Q (<xref ref-type="bibr" rid="bib23">Halt et al., 2012</xref>). We first used PLA to measure association of GluN2B-iHA variants and endogenous CaMKII (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). Anti-HA/anti-CaMKIIα puncta were visible at 0.66±0.04 per 10 μm dendrite in neurons expressing WT GluN2B-iHA, rising to 1.23±0.04 (p=1 × 10<sup>–11</sup>) following NMDAR activation whereas puncta were at baseline levels in the absence of GluN2B-iHA expression (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Puncta formation was suppressed in neurons expressing GluN2B-iHA ΔCaMKII with 0.29±0.02 puncta per 10 μm dendrite in naïve neurons rising to only 0.40±0.02 (p=3.7 × 10<sup>–4</sup>) following NMDAR activation. Analysis of this data using two-way ANOVA supports an interaction between NMDAR activation and mutation of the CaMKII anchoring site (p=3.2 × 10<sup>–10</sup>), consistent with the notion that CaMKII docks to this site during LTP.</p><p>Next, we measured anti-HA/anti-FLAG PLA puncta formation in neurons expressing GluN2B-iHA variants and FLAG-α-actinin-2 (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). Puncta formed at a frequency of 0.47±0.02 per 10 μm dendrite in naïve neurons expressing WT GluN2B-iHA and FLAG-α-actinin-2, rising 30 ± 6% to 0.61±0.02 following NMDAR activation (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Puncta formation was at baseline levels if either protein was expressed in isolation (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). In neurons expressing GluN2B-iHA ΔCaMKII and FLAG-α-actinin-2, NMDAR activation only elevated puncta levels by 11 ± 5% from 0.38±0.01 to 0.42±0.01 per 10 μm dendrite (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Analysis of the data presented in <xref ref-type="fig" rid="fig6">Figure 6H</xref> by two-way ANOVA indicates an interaction between the presence of the CaMKII anchoring site and NMDAR activation (p=9 × 10<sup>–3</sup>), which supports a mechanism in which CaMKII docking to GluN2B plays at least some role in supporting elevated CaMKII-α-actinin-2 association following structural LTP.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We propose a revised mechanism for spine enlargement in structural LTP (<xref ref-type="fig" rid="fig7">Figure 7</xref>) based on our findings. In naïve spines, the regulatory segment of CaMKII is sequestered by its kinase domain (<xref ref-type="fig" rid="fig7">Figure 7A</xref>) within inactive dodecamers, ensuring only limited association with α-actinin-2 in the ground state (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Upon induction of LTP by Ca<sup>2+</sup> influx through NMDARs, activated Ca<sup>2+</sup>/CaM binds to the regulatory segment of CaMKII which exposes the substrate-binding groove of the kinase domain (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The activated kinase phosphorylates key substrates including AMPA receptors and forms a highly stable complex with NMDARs by interaction with a substrate-binding site within the C-tail of GluN2B subunits. The duration of CaMKII activation is prolonged beyond the duration of Ca<sup>2+</sup> elevation by auto-phosphorylation at T286, although pT286 autonomy is reversed by phosphatases including protein phosphatase 1 within ~10 s (<xref ref-type="bibr" rid="bib71">Yasuda et al., 2022</xref>). In complex with NMDARs, the substrate-binding groove of the CaMKII kinase domain is occupied (<xref ref-type="bibr" rid="bib40">Özden et al., 2022</xref>), which leaves the regulatory segment accessible to interact with α-actinin-2 (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) enabling new interactions between the two to be established within the first 2 min of LTP induction. In this way, α-actinin-2 is enriched in dendritic spine heads where it supports spine head enlargement through its ability to crosslink actin filaments via its N-terminal actin-binding domain (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). This updated mechanism fits with an influential ‘synaptic tagging’ theory (<xref ref-type="bibr" rid="bib54">Sanhueza and Lisman, 2013</xref>), whereby long-lasting CaMKII-NMDAR complexes formed during LTP induction serve as primers for more global structural changes in dendritic spines that occur after the initial Ca<sup>2+</sup> signal has subsided.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Model of actinin-calmodulin-dependent protein kinase II (CaMKII) dynamics underlying structural long-term potentiation (LTP).</title><p>A three-stage model is presented with close-up illustrations of protein interactions involving CaMKII on the right for each stage. (<bold>A</bold>) In naïve synapses prior to Ca<sup>2+</sup> entry, the CaMKII regulatory segment associates with the kinase domain and is largely inaccessible to α-actinin-2. (<bold>B</bold>) Ca<sup>2+</sup> influx through NMDA receptors (NMDARs) triggers binding of Ca<sup>2+</sup>/CaM (purple) to the regulatory segment, enabling docking of the kinase domain to the C-terminal tail of GluN2B (gold) subunits. (<bold>C</bold>) Following return of spine [Ca<sup>2+</sup>] to baseline levels, Ca<sup>2+</sup>/CaM dissociates whereas CaMKII-NMDAR interactions persist. This combination enables α-actinin-2 to dock to the kinase domain, thereby linking the kinase to the actin cytoskeleton in support of spine enlargement.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85008-fig7-v3.tif"/></fig><p>The simplified model presented in <xref ref-type="fig" rid="fig7">Figure 7</xref> is broadly consistent with many additional protein-protein interactions involving CaMKII and α-actinins that are known to contribute to the positioning of the two proteins in dendritic spines. Densin-180 includes a C-terminal PDZ domain that binds to the PDZ ligand at the C-terminus of α-actinin-2 (<xref ref-type="bibr" rid="bib66">Walikonis et al., 2001</xref>), and a motif ~100–150 amino acids from its C-terminus that associates with the CaMKII hub domain (<xref ref-type="bibr" rid="bib62">Strack et al., 2000b</xref>). Earlier studies have shown that CaMKII can form tripartite complexes with densin-180, α-actinin-2, and GluN2B (<xref ref-type="bibr" rid="bib50">Robison et al., 2005b</xref>). In the crystal structure (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), the PDZ ligand at the C-terminus of EF3–4 is available for interaction which suggests that densin-180 could form a tripartite complex with CaMKII and α-actinin including a single CaMKII protomer. α-Actinin-2 is also known to interact with other NMDAR subunits and PSD-95. α-Actinin-2 binds to the C-tails of GluN1 subunits (<xref ref-type="bibr" rid="bib69">Wyszynski et al., 1997</xref>) through its central spectrin repeats (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), which could be compatible with binding to CaMKII associated with GluN2B subunits. α-Actinins also associate with the N-terminal 13 amino acids of PSD-95, which underlie their role in spine formation (<xref ref-type="bibr" rid="bib32">Matt et al., 2018</xref>), further supporting a role for the actin-crosslinking protein in the PSD. α-Actinin-2 has previously been shown to enhance binding of CaMKII to GluN2B (<xref ref-type="bibr" rid="bib28">Jalan-Sakrikar et al., 2012</xref>), therefore it is logical that the reverse should also be true according to the principle of reciprocity. Our ITC measurements indicate that EF1–4 binds to the CaMKII regulatory segment with somewhat higher affinity than EF3–4 (<xref ref-type="fig" rid="fig3">Figure 3</xref>), so there is some remaining uncertainty concerning the exact contribution of the EF1–2 region to interaction with CaMKII in neurons. Accurately conceptualising interactions between proteins in the PSD is complicated by the potential for cooperative interactions since many of the relevant proteins are oligomeric. For example, it is not clear whether EF3–4 domains at either end of an α-actinin-2 dimer could simultaneously bind to two regulatory segments within the same CaMKII dodecamer (<xref ref-type="bibr" rid="bib44">Penny and Gold, 2018</xref>). Furthermore, NMDAR receptors themselves are spaced at regular intervals of ~30 nm in the PSD (<xref ref-type="bibr" rid="bib10">Chen et al., 2008</xref>) – a similar scale to the width of CaMKII dodecamers (~25 nm) and the length of α-actinin-2 dimers (~28 nm) (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Myers et al., 2017</xref>) – raising the possibility of cooperative interactions spanning multiple receptors. Developments in techniques for in situ imaging including cryo-electron tomography (<xref ref-type="bibr" rid="bib64">van den Hoek et al., 2022</xref>) will be required to resolve the extent to which cooperative interactions support the structure of potentiated dendritic spines.</p><p>Our imaging experiments fit with previous reports that α-actinin-2 knockdown prevents formation of mushroom-type dendritic spines (<xref ref-type="bibr" rid="bib26">Hodges et al., 2014</xref>). α-Actinin-2 is best known for its role at the Z-dics in cardiac, striated, and smooth muscle cells where it organises the lattice structure of the contractile apparatus through crosslinking actin filaments and binding titin through the EF3–4 region (<xref ref-type="bibr" rid="bib59">Sjöblom et al., 2008</xref>). Actin is not visible in equivalent arrays with regular spacing in dendritic spines (<xref ref-type="bibr" rid="bib7">Burette et al., 2012</xref>). In this location, α-actinins likely operate through a mechanism more analogous to their role during cytokinesis where they accumulate actin filaments at the cleavage furrow without generating a regular lattice structure (<xref ref-type="bibr" rid="bib35">Mukhina et al., 2007</xref>). An aspect of CaMKII regulation of spine architecture that we did not consider in this study is the role of CaMKIIβ subunits, that bind directly to the actin cytoskeleton through elements within their regulatory segment (<xref ref-type="bibr" rid="bib37">O’Leary et al., 2006</xref>; <xref ref-type="bibr" rid="bib57">Shen et al., 1998</xref>). Only a fraction of CaMKII dodecamers contain β subunits (<xref ref-type="bibr" rid="bib34">Miller and Kennedy, 1985</xref>) but within these assemblies it is possible that tripartite complexes assemble including CaMKII, α-actinin, and F-actin. In our summary model (<xref ref-type="fig" rid="fig7">Figure 7</xref>), we suggest that docking to NMDARs is key for enabling α-actinin-2 to access the CaMKII regulatory segment but other postsynaptic proteins that stably associate with CaMKII by occupying the substrate-binding groove of the kinase domain such as Tiam1 (<xref ref-type="bibr" rid="bib52">Saneyoshi et al., 2019</xref>) could also support activity-dependent increases in CaMKII-actinin association. There is potential for therapeutic inhibition of CaMKII (<xref ref-type="bibr" rid="bib43">Pellicena and Schulman, 2014</xref>), and several leading peptide inhibitors of the kinase constitute pseudosubstrate sequences that occupy the substrate-binding groove (<xref ref-type="bibr" rid="bib48">Reyes Gaido et al., 2023</xref>). Our work suggests that developers of such inhibitors should be mindful of the potential for unexpected gain-of-function effects in inhibitors that increase access to the regulatory segment. Overall, our study illuminates the remarkable sophistication of regulatory processes that enable a single kinase – CaMKII – to play such a central role in the regulation of synaptic strength.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Protein expression and purification</title><p>The EF3–4 (827–894) region of human α-actinin-2 was cloned into a modified pET28 vector using primers EF34_F &amp; _R for expression with a Tev-cleavable N-terminal 6His-GST tag. The construct was transformed into Rosetta plysS <italic>Escherichia coli</italic>, and expression was induced with 1 mM IPTG after the cells had reached an OD<sub>600nm</sub> of ~0.7 in LB. Cells were harvested after overnight incubation at 20°C, resuspended in Ni-NTA buffer A (25 mM Tris pH 8, 500 mM NaCl, 1 mM benzamidine, 30 mM imidazole) supplemented with 1 cOmplete protease inhibitor tablet/100 mL and 0.1 mg/mL lysozyme, then clarified by centrifugation at 40,000 × <italic>g</italic>. The clarified lysate was incubated with Ni-NTA agarose beads (QIAGEN) for 1.5 hr. Following incubation, beads were washed and eluted (500 mM NaCl, 25 mM Tris pH 7.5, 1 mM benzamidine, 300 mM imidazole). The resulting eluate was buffer exchanged into Glutathione Sepharose binding buffer (25 mM HEPES pH 7.5, 500 mM NaCl, 1 mM DTT, 0.5 mM EDTA) and incubated with Glutathione Sepharose 4B beads for 3 hr, washed and cleaved overnight at 4°C with Tev protease. Following overnight cleavage, samples were further purified by size-exclusion chromatography with a HiLoad 16/600 Superdex 75 column equilibrated in 20 mM Na HEPES pH 7.5, 0.15 M NaCl, and 1 mM DTT.</p><p>Coding sequences for rat GluN2B (1260–1492) and α-actinin-2 EF1–4 (747–894) were cloned into pGEX-6P1 using primers BamHI_GluN2B_1260/GluN2B_Term_EcoRI and EcoRI_actinin_747/actinin_Term_NotI, respectively. GluN2Bc was expressed in Tuner (DE3) <italic>E. coli</italic> whereas EF1–4 was expressed in Rosetta plysS <italic>E. coli</italic>. In both cases, bacteria were harvested following overnight growth in auto-inducing media (AIM) (<xref ref-type="bibr" rid="bib63">Studier, 2005</xref>) at 37°C. The two protein fragments were purified in the same way. Bacteria were first lysed by sonication in lysis buffer (25 mM HEPES pH 7.5, 500 mM NaCl, 1 mM benzamidine, 1 mM DTT, 1 mM EDTA) supplemented with 1 cOmplete protease inhibitor tablet/100 mL and 0.1 mg/mL lysozyme, then clarified by centrifugation at 40,000 × <italic>g</italic>. Lysates were incubated with 3 mL Glutathione Sepharose 4B for 3 hr, washed and cleaved from immobilised GST fusion tag by overnight incubation with PreScission protease at 4°C. Finally, the proteins were subjected to size-exclusion chromatography with a HiLoad 16/600 Superdex 75 column equilibrated in 25 mM HEPES pH 7.5 and 150 mM NaCl. Template DNA for GluN2B (vector pCI-EGFP-NR2b) was provided by Andres Barria &amp; Robert Malinow (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_45447">Addgene_45447</ext-link>) (<xref ref-type="bibr" rid="bib3">Barria and Malinow, 2002</xref>), and α-actinin-2 coding sequence by Kristina Djinović-Carugo (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>).</p><p>N-terminally 6His-tagged mouse CaMKIIα was cloned into pcDNA3.1 using primers EcoRI_6HisCaMKIIa and CaMKIIa_Term_XhoI for expression in adherent HEK293T cells. Cells were transfected at 60–70% confluency with 10 μg DNA and 60 μg polyethlyenimine (MW 25000) applied to each 10 cm dish (<xref ref-type="bibr" rid="bib13">Curtis et al., 2022</xref>). The media was replaced with DMEM supplemented with 10% FBS the morning after transfection, and cells were harvested 3 days after transfection. Cells were lysed by Dounce homogenisation in lysis buffer (20 mM HEPES pH 8.0, 20 mM NaCl, 2 mM DTT, 1 mM EDTA, 1 cOmplete protease inhibitor tablet/100 mL) and clarified by centrifugation for 30 min at 45,000 × <italic>g</italic>. CaMKII was initially enriched using anion exchange with Q Sepharose Fast Flow resin (GE Healthcare), eluted in high salt buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 2 mM DTT, and 1 mM EDTA) following 2 hr incubation. This eluate was exchanged into Ni-NTA buffer A (500 mM NaCl, 25 mM Tris pH 8, 1 mM benzamidine, 20 mM imidazole) using a HiPrep desalting column (Cytiva) for binding to Ni-NTA agarose. His-CaMKIIα was eluted from the Ni-NTA agarose using a gradient into Ni-NTA buffer B (500 mM NaCl, 25 mM Tris pH 7.5, 1 mM benzamidine, 300 mM imidazole), and finally exchanged into storage buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 10% wt/vol glycerol). For expression of CaMKIIα 1–315, the corresponding coding sequence was cloned into pNH-TrxT (gift of Opher Gileadi)(<xref ref-type="bibr" rid="bib55">Savitsky et al., 2010</xref>) for expression with a Tev-cleavable N-terminal 6His-Trx tag in bacteria using primers pNH-Trx CaMKII_1–315_F &amp; _R. The expression vector was transformed into Rosetta (DE3) pLysS <italic>E. coli</italic>, which were grown in LB and induced with 0.2 mM IPTG at OD<sub>600 nm</sub> ~0.5. Cells were harvested following overnight incubation at 18°C, then lysed in Ni-NTA buffer A (25 mM Tris pH 8, 500 mM NaCl, 1 mM benzamidine, 20 mM imidazole) supplemented with 0.1 mg/mL lysozyme and 1 Complete EDTA-free protease inhibitor tablet/100 mL. 6His-Trx-CaMKIIα (1-315) was initially purified by affinity to Ni-NTA agarose, eluting with a gradient into nickel buffer B. The eluate was exchanged into anion exchange buffer A (20 mM Tris pH 8.8, 20 mM NaCl, 1 mM DTT, 1 mM EDTA) using a HiPrep 26/10 desalting column to enable binding to a Q Fast Flow column (Cytiva). Protein was eluted using a gradient into anion exchange buffer B (20 mM Tris, pH 8, 500 mM NaCl, 1 mM DTT, 1 mM EDTA). Finally, size exclusion was performed using a HiLoad Superdex 75 column equilibrated in gel filtration buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT).</p><p>Human CaM was expressed and purified as described previously (<xref ref-type="bibr" rid="bib41">Patel et al., 2017</xref>). Briefly, untagged CaM was expressed using pET28-a in <italic>E. coli</italic> BL21 (DE3) cells grown in AIM. CaM was initially purified by affinity to phenyl sepharose (GE Life Sciences) in the presence of 5 mM CaCl<sub>2</sub>. CaM was eluted in buffer containing 1 mM EDTA then further purified using anion exchange with a Resource Q column (GE Life Sciences) before dialysis into water and lyophilisation in a vacuum concentrator.</p></sec><sec id="s4-2"><title>Crystallography</title><p>For crystallisation of α-actinin-2 EF3–4 with CaMKIIα regulatory segment, peptide corresponding to CaMKIIα positions 294–315 (sequence NARRKLKGAILTTMLATRNFSG, acetylated at N-terminus, amidated at C-terminus) was synthesised by Biomatik at &gt;95% purity. α-Actinin-2 EF3–4 (16 mg/mL) was mixed with a 2.5-fold molar excess of CaMKIIα peptide in a precipitant solution containing 0.1 M Bis-Tris pH 6.5, 25% wt/vol polyethylene glycol 3350, and crystals were grown by sitting drop vapor diffusion at 24°C. Diffraction data was collected to high resolution at Diamond Light Source beamline I04 with X-rays at a wavelength of 0.9795 Å, and at beam line P13 at the PETRA III storage ring (DESY, Hamburg, Germany) with X-rays tuned to 2.0664 Å to amplify the anomalous signal of sulfur. Diffraction data was reduced using DIALS (<xref ref-type="bibr" rid="bib68">Winter et al., 2018</xref>) and scaled with Aimless (<xref ref-type="bibr" rid="bib17">Evans and Murshudov, 2013</xref>) before experimental phasing using single-wavelength anomalous diffraction of native sulfur atoms in CRANK2 (<xref ref-type="bibr" rid="bib60">Skubák et al., 2018</xref>). Refinement was completed in PHENIX (<xref ref-type="bibr" rid="bib29">Liebschner et al., 2019</xref>). The following residues were omitted from the final model since they could not be clearly resolved in the electron density: EF3–4 892–894 (chain B); CaMKIIα 314–315 (chain C); and CaMKIIα 311–315 (chain D). Full data collection and refinement statistics are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-3"><title>Isothermal titration calorimetry</title><p>ITC experiments were performed using a MicroCal PEAQ (Malvern Panalyticial). To investigate binding between CaMKII peptides and EF1–4/EF3–4, experiments were performed at 25°C in 25 mM HEPES pH 7.5 and 150 mM NaCl, where 500 μM CaMKII peptides were injected into a cell containing 50 μM EF1–4/EF3–4 using 2 μL injections at 2 min intervals and a constant mixing speed of 750 rpm. Measurements between Trx-CaMKIIα 1–315 and EF3–4 were performed using 30 μM Trx-CaMKIIα 1–315 and 300 μM of EF hands 3–4 and additionally supplementing the buffer with 2 mM MgCl<sub>2</sub> and 1 mM ADP. To investigate CaMKII-CaM interactions, ITC was performed at 10°C using 30 μM Trx-CaMKIIα 1–315 – 300 μM CaM (buffer supplemented with 2 mM MgCl<sub>2</sub>, 1 mM ADP, and 1 mM CaCl<sub>2</sub>); and 30 μM CaM – 300 μM CaMKII regulatory peptide (buffer supplemented with 1 mM CaCl<sub>2</sub>). Protein concentrations were determined using a combination of absorbance at A<sub>280</sub> (with reference to theoretical extinction coefficients) and bicinchoninic acid assays. Single protein preparations were used for experimental replicates with the exception of EF3–4, where two preparations were used. Each preparation of EF3–4 yielded similar results. All ITC measurements were collected, baselined, and integrated before non-linear least-squares fitting to single binding models using MicroCal origin software.</p></sec><sec id="s4-4"><title>Culture and transfection of primary hippocampal neurons</title><p>Primary hippocampal cultures were prepared from E18 Sprague-Dawley rats and plated onto 13 mm coverslips, pre-treated with poly-L-lysine (1 mg/mL) at a density of 1×10<sup>5</sup> cells per coverslip. Neurons were cultured in neurobasal medium supplemented with B27, GlutaMAX, and Penicillin/Streptomycin. On DIV10, neurons were transfected with 0.8 μg DNA and 2 μL Lipofectamine 2000 per 13 mm coverslip in six-well plates. For double transfections, 0.4 μg of each vector was included in the transfection mixture in all cases. After transferring transfected neurons into fresh media on DIV11, in vitro culture was continued until chemical LTP/fixing on DIV14.</p><p>pIRES2-GFP vectors containing N-terminally FLAG-tagged coding sequences were constructed using primers listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The L854R mutation was introduced into pcDNA3.1-FLAG-α-actinin-2 (747–894) by site-directed mutagenesis with primers L854R_F &amp; _R. pIRES2-EGFP vector for expressing N-terminally V5-tagged CaMKIIα was generated using primers BamHI_V5_CaMKII_F and CaMKII_Term_SalI_R. Site-directed mutagenesis was used to generate alanine substitutions in this vector as follows: T286A_F/R for the T286A variant; T305A_F/R for T305A; and T306A_F/R for T306A. For expression of GFP-GluN2B subunits containing internal HA tags, we used primers AgeI_4gHA4g_F and EcoRI_GluN2B_R to insert a 4Gly-HA-4Gly sequence after position G1211 in a GFP-GluN2B vector (<xref ref-type="bibr" rid="bib31">Luo et al., 2002</xref>). We used site-directed mutagenesis with primers CaMKIIa_AQ_F and CaMKIIa_AQ_R to generate the ΔCaMKII variant of this construct.</p></sec><sec id="s4-5"><title>Chemical LTP</title><p>Chemical LTP (cLTP) was induced in cultured hippocampal neurons by activating NMDARs with glycine as described previously (<xref ref-type="bibr" rid="bib19">Fortin et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">McLeod et al., 2018</xref>). Primary hippocampal neurons were first transferred into control solution (5 mM HEPES pH 7.4, 125 mM NaCl, 2.5 mM KCl, 1 mM MgCl<sub>2</sub>, 2 mM CaCl<sub>2</sub>, 33 mM D-glucose, 20 μM D-APV, 3 μM strychnine, 20 μM bicuculline, 0.5 μM TTX) for 20 min at room temperature (RT). cLTP was induced by incubating for 10 min at RT in cLTP solution (5 mM HEPES pH 7.4, 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl<sub>2</sub>, 33 mM D-glucose, 3 μM strychnine, 20 μM bicuculline, 0.2 mM glycine). Following cLTP induction, neurons were returned to control solution for between 1 and 4 hr before fixation in fixing solution (PBS supplemented with 4% paraformaldehyde, 4% sucrose, 0.2% glutaraldehyde). For PLA assays, neurons were fixed 2 hr after cLTP induction other than in the time course experiment (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), in which they were fixed either 10, 30, 120, 600, or 3600 s after the initial addition of cLTP solution. For the longest time-point, the neurons were returned to control solution after 10 min.</p></sec><sec id="s4-6"><title>PLAs and confocal imaging</title><p>PLAs were performed using reagents from Duolink In Situ PLA kits. Fixed neurons were permeabilised for 5 min at RT in PBS supplemented with 1% BSA/0.1% Triton X-100, and blocked for 1 hr in PBS supplemented with 10% BSA before overnight incubation at 4°C with primary antibodies (mouse anti-CaMKIIα, 1 in 400 dilution; goat anti-FLAG, 1 in 200 dilution; rabbit anti-GFP, 1 in 300 dilution; rabbit anti-HA, 1 in 500 dilution, mouse anti-V5, 1 in 500 dilution) in PBS supplemented with 1% BSA. On the following morning, neurons were incubated with the corresponding Duolink probes (anti-goat PLUS with either anti-mouse MINUS or anti-rabbit MINUS) and goat anti-rabbit Alexa Fluor-405 (Thermo Fisher) at 37°C for 1 hr. Probes were ligated at 37°C for 30 min and signals were amplified at 37°C for 100 min. Neurons were imaged using ZEN software and a 60× oil objective NA = 1.40 using either a Zeiss LSM 700 inverted microscope (data presented in <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig3">3</xref>) or an LSM 780 microscope equipped with an airyscan module (data presented in <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig6">6</xref>). For PLA experiments, images were collected using 405 nm excitation/421 nm emission for GFP, and 594 nm excitation/619 nm emission for PLA puncta. For imaging neurons transfected with α-actinin-2 EF1–4 disruptors, intrinsic GFP fluorescence was imaged using 488 nm excitation/509 nm emission. Data were obtained from at least three independent neuronal cultures unless otherwise stated. Images were analysed using NeuronStudio software (Icahn School of Medicine at Mount Sinai) to determine spine width and morphology; and the Distance Analysis (DiAna) plugin (<xref ref-type="bibr" rid="bib20">Gilles et al., 2017</xref>) for ImageJ (NIH) to identify PLA puncta.</p></sec><sec id="s4-7"><title>Magnetic bead pull-down assays</title><p>For each CaMKIIα pull-down assay, 0.25 μg of Pierce Glutathione Magnetic Agarose Beads were charged with 4 μg GST or GST-EF1–4 in basic binding buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween-20, 10 mM MgCl<sub>2</sub>, 0.5 mM ADP, 2 mM DTT) for 2 hr at 4°C. Protein mixtures containing CaMKII, CaM, and GluN2Bc (as appropriate) were separately pre-incubated for 1 hr in basic binding buffer supplemented with CaCl<sub>2</sub>. These mixtures were diluted with equal volumes of basic binding buffer containing 4% BSA to achieve final concentrations of 2 mM CaCl<sub>2</sub>, 2% BSA, 0.1 μM CaMKIIα, 3 μM CaM, and 1.5 μM GluN2Bc as appropriate. For each assay, 100 μL protein mixture was incubated with GST/GST-EF1–4 magnetic beads for 20 min before the reactions were supplemented with either 10, 2.5, or 1.8 mM EGTA. Free Ca<sup>2+</sup> concentrations were estimated using maxchelator (<xref ref-type="bibr" rid="bib5">Bers et al., 2010</xref>). Following 20 min further incubation, each pull-down was washed with 3×500 μL basic binding buffer supplemented with 2 mM CaCl<sub>2</sub> and the appropriate concentration of EGTA. Proteins were eluted from the beads by incubation with 50 μL 1× LDS loading buffer (5 min heating at 65°C). CaMKII and GST/GST-EF1–4 were detected using immunoblotting with mouse anti-CaMKIIα and rabbit anti-GST antibodies.</p></sec><sec id="s4-8"><title>Statistical analysis</title><p>Data were assessed for normality using Kolmogorov-Smirnov testing. Normally distributed data were analyzed using unpaired two-tailed Student’s t-tests whereas Mann-Whitney tests were applied for non-parametric data. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001. Two-way ANOVA was utilised to analyse PLA measurements with neurons expressing GluN2B-iHA. Non-linear curve fitting by iterative least squares minimisation was performed in Origin (OriginLab) to fit PLA time course data to a Hill function.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Experiments involving rats were performed in accordance with the United Kingdom Animals Act, 1986 and within University College London Animal Research guidelines overseen by the UCL Animal Welfare and Ethical Review Body under project code 14058.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Data collection and refinement statistics.</title></caption><media xlink:href="elife-85008-supp1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Oligonucleotide primers sequences.</title><p>Primer sequences are shown (5’ to 3’).</p></caption><media xlink:href="elife-85008-supp2-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85008-mdarchecklist1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Coordinates and structure factors have been deposited with the RCSB Protein Databank for the EF3-4 - CaMKII regulatory segment peptide complex with accession ID 6TS3.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Gold</surname><given-names>M G</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>EF-hands 3 and 4 of alpha-actinin in complex with CaMKII regulatory segment</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/6ts3">6TS3</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by BBSRC project grant BB/N015274/1, a Wellcome Trust and Royal Society Sir Henry Dale fellowship to MGG (104194/Z/14/Z), and a BBSRC studentship to AC. We are grateful to Opher Gileadi, Andres Barria, Robert Malinow, and Kristina Djinović-Carugo for providing DNA vectors in support of this work.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anggono</surname><given-names>V</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of AMPA receptor trafficking and synaptic plasticity</article-title><source>Current Opinion in Neurobiology</source><volume>22</volume><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2011.12.006</pub-id><pub-id pub-id-type="pmid">22217700</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcomb</surname><given-names>K</given-names></name><name><surname>Buard</surname><given-names>I</given-names></name><name><surname>Coultrap</surname><given-names>SJ</given-names></name><name><surname>Kulbe</surname><given-names>JR</given-names></name><name><surname>O’Leary</surname><given-names>H</given-names></name><name><surname>Benke</surname><given-names>TA</given-names></name><name><surname>Bayer</surname><given-names>KU</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength</article-title><source>FASEB Journal</source><volume>28</volume><fpage>3810</fpage><lpage>3819</lpage><pub-id pub-id-type="doi">10.1096/fj.14-250407</pub-id><pub-id pub-id-type="pmid">24843070</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barria</surname><given-names>A</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Subunit-specific NMDA receptor trafficking to synapses</article-title><source>Neuron</source><volume>35</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(02)00776-6</pub-id><pub-id pub-id-type="pmid">12160751</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>KU</given-names></name><name><surname>De Koninck</surname><given-names>P</given-names></name><name><surname>Leonard</surname><given-names>AS</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Interaction with the NMDA receptor locks CaMKII in an active conformation</article-title><source>Nature</source><volume>411</volume><fpage>801</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1038/35081080</pub-id><pub-id pub-id-type="pmid">11459059</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Patton</surname><given-names>CW</given-names></name><name><surname>Nuccitelli</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A practical guide to the preparation of Ca(2+) buffers</article-title><source>Methods in Cell Biology</source><volume>99</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374841-6.00001-3</pub-id><pub-id pub-id-type="pmid">21035681</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>M</given-names></name><name><surname>Karandur</surname><given-names>D</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural insights into the regulation of Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase II (CaMKII)</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>12</volume><elocation-id>a035147</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a035147</pub-id><pub-id pub-id-type="pmid">31653643</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burette</surname><given-names>AC</given-names></name><name><surname>Lesperance</surname><given-names>T</given-names></name><name><surname>Crum</surname><given-names>J</given-names></name><name><surname>Martone</surname><given-names>M</given-names></name><name><surname>Volkmann</surname><given-names>N</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Electron tomographic analysis of synaptic ultrastructure</article-title><source>The Journal of Comparative Neurology</source><volume>520</volume><fpage>2697</fpage><lpage>2711</lpage><pub-id pub-id-type="doi">10.1002/cne.23067</pub-id><pub-id pub-id-type="pmid">22684938</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JY</given-names></name><name><surname>Parra-Bueno</surname><given-names>P</given-names></name><name><surname>Laviv</surname><given-names>T</given-names></name><name><surname>Szatmari</surname><given-names>EM</given-names></name><name><surname>Lee</surname><given-names>SJR</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CaMKII Autophosphorylation is necessary for optimal integration of Ca<sup>2+</sup> Signals during LTP induction, but not maintenance</article-title><source>Neuron</source><volume>94</volume><fpage>800</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.041</pub-id><pub-id pub-id-type="pmid">28521133</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>LH</given-names></name><name><surname>Stratton</surname><given-names>MM</given-names></name><name><surname>Lee</surname><given-names>IH</given-names></name><name><surname>Rosenberg</surname><given-names>OS</given-names></name><name><surname>Levitz</surname><given-names>J</given-names></name><name><surname>Mandell</surname><given-names>DJ</given-names></name><name><surname>Kortemme</surname><given-names>T</given-names></name><name><surname>Groves</surname><given-names>JT</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A mechanism for tunable autoinhibition in the structure of A human Ca2+/calmodulin- dependent kinase II holoenzyme</article-title><source>Cell</source><volume>146</volume><fpage>732</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.07.038</pub-id><pub-id pub-id-type="pmid">21884935</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Winters</surname><given-names>C</given-names></name><name><surname>Azzam</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Galbraith</surname><given-names>JA</given-names></name><name><surname>Leapman</surname><given-names>RD</given-names></name><name><surname>Reese</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Organization of the core structure of the postsynaptic density</article-title><source>PNAS</source><volume>105</volume><fpage>4453</fpage><lpage>4458</lpage><pub-id pub-id-type="doi">10.1073/pnas.0800897105</pub-id><pub-id pub-id-type="pmid">18326622</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citri</surname><given-names>A</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synaptic plasticity: multiple forms, functions, and mechanisms</article-title><source>Neuropsychopharmacology</source><volume>33</volume><fpage>18</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301559</pub-id><pub-id pub-id-type="pmid">17728696</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>S</given-names></name><name><surname>Almeida</surname><given-names>A</given-names></name><name><surname>Castro</surname><given-names>A</given-names></name><name><surname>Domingues</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fusion tags for protein solubility, purification and immunogenicity in <italic>Escherichia coli</italic>: the novel Fh8 system</article-title><source>Frontiers in Microbiology</source><volume>5</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2014.00063</pub-id><pub-id pub-id-type="pmid">24600443</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>AJ</given-names></name><name><surname>Dowsell</surname><given-names>RS</given-names></name><name><surname>Gold</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Assaying protein kinase A activity using A FRET-Based sensor purified from mammalian cells</article-title><source>Methods in Molecular Biology</source><volume>2483</volume><fpage>15</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-2245-2_2</pub-id><pub-id pub-id-type="pmid">35286667</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ribeiro</surname><given-names>EA</given-names></name><name><surname>Pinotsis</surname><given-names>N</given-names></name><name><surname>Ghisleni</surname><given-names>A</given-names></name><name><surname>Salmazo</surname><given-names>A</given-names></name><name><surname>Konarev</surname><given-names>PV</given-names></name><name><surname>Kostan</surname><given-names>J</given-names></name><name><surname>Sjöblom</surname><given-names>B</given-names></name><name><surname>Schreiner</surname><given-names>C</given-names></name><name><surname>Polyansky</surname><given-names>AA</given-names></name><name><surname>Gkougkoulia</surname><given-names>EA</given-names></name><name><surname>Holt</surname><given-names>MR</given-names></name><name><surname>Aachmann</surname><given-names>FL</given-names></name><name><surname>Zagrović</surname><given-names>B</given-names></name><name><surname>Bordignon</surname><given-names>E</given-names></name><name><surname>Pirker</surname><given-names>KF</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name><name><surname>Gautel</surname><given-names>M</given-names></name><name><surname>Djinović-Carugo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The structure and regulation of human muscle α-actinin</article-title><source>Cell</source><volume>159</volume><fpage>1447</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.056</pub-id><pub-id pub-id-type="pmid">25433700</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhavan</surname><given-names>R</given-names></name><name><surname>Greer</surname><given-names>PL</given-names></name><name><surname>Morabito</surname><given-names>MA</given-names></name><name><surname>Orlando</surname><given-names>LR</given-names></name><name><surname>Tsai</surname><given-names>L-H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>7879</fpage><lpage>7891</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-18-07879.2002</pub-id><pub-id pub-id-type="pmid">12223541</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erondu</surname><given-names>NE</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain</article-title><source>The Journal of Neuroscience</source><volume>5</volume><fpage>3270</fpage><lpage>3277</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.05-12-03270.1985</pub-id><pub-id pub-id-type="pmid">4078628</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>PR</given-names></name><name><surname>Murshudov</surname><given-names>GN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>How good are my data and what is the resolution?</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>69</volume><fpage>1204</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1107/S0907444913000061</pub-id><pub-id pub-id-type="pmid">23793146</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forest</surname><given-names>A</given-names></name><name><surname>Swulius</surname><given-names>MT</given-names></name><name><surname>Tse</surname><given-names>JKY</given-names></name><name><surname>Bradshaw</surname><given-names>JM</given-names></name><name><surname>Gaertner</surname><given-names>T</given-names></name><name><surname>Waxham</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of the N- and C-lobes of calmodulin in the activation of Ca(2+)/calmodulin-dependent protein kinase II</article-title><source>Biochemistry</source><volume>47</volume><fpage>10587</fpage><lpage>10599</lpage><pub-id pub-id-type="doi">10.1021/bi8007033</pub-id><pub-id pub-id-type="pmid">18795794</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname><given-names>DA</given-names></name><name><surname>Davare</surname><given-names>MA</given-names></name><name><surname>Srivastava</surname><given-names>T</given-names></name><name><surname>Brady</surname><given-names>JD</given-names></name><name><surname>Nygaard</surname><given-names>S</given-names></name><name><surname>Derkach</surname><given-names>VA</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-term potentiation-dependent spine enlargement requires synaptic Ca2+-permeable AMPA receptors recruited by CaM-kinase I</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>11565</fpage><lpage>11575</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1746-10.2010</pub-id><pub-id pub-id-type="pmid">20810878</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilles</surname><given-names>JF</given-names></name><name><surname>Dos Santos</surname><given-names>M</given-names></name><name><surname>Boudier</surname><given-names>T</given-names></name><name><surname>Bolte</surname><given-names>S</given-names></name><name><surname>Heck</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DiAna, an ImageJ tool for object-based 3D co-localization and distance analysis</article-title><source>Methods</source><volume>115</volume><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2016.11.016</pub-id><pub-id pub-id-type="pmid">27890650</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grison</surname><given-names>M</given-names></name><name><surname>Merkel</surname><given-names>U</given-names></name><name><surname>Kostan</surname><given-names>J</given-names></name><name><surname>Djinović-Carugo</surname><given-names>K</given-names></name><name><surname>Rief</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>α-Actinin/titin interaction: A dynamic and mechanically stable cluster of bonds in the muscle Z-disk</article-title><source>PNAS</source><volume>114</volume><fpage>1015</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1073/pnas.1612681114</pub-id><pub-id pub-id-type="pmid">28096424</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>DD</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Tseng</surname><given-names>PY</given-names></name><name><surname>Malik</surname><given-names>Z</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Matt</surname><given-names>L</given-names></name><name><surname>Schnizler</surname><given-names>K</given-names></name><name><surname>Shephard</surname><given-names>A</given-names></name><name><surname>Mohapatra</surname><given-names>DP</given-names></name><name><surname>Tsuruta</surname><given-names>F</given-names></name><name><surname>Dolmetsch</surname><given-names>RE</given-names></name><name><surname>Christel</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Burette</surname><given-names>A</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Competition between α-actinin and Ca</article-title><source>Neuron</source><volume>78</volume><fpage>483</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.032</pub-id><pub-id pub-id-type="pmid">23664615</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halt</surname><given-names>AR</given-names></name><name><surname>Dallapiazza</surname><given-names>RF</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Stein</surname><given-names>IS</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Juntti</surname><given-names>S</given-names></name><name><surname>Wojcik</surname><given-names>S</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>CaMKII binding to GluN2B is critical during memory consolidation</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>1203</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.482</pub-id><pub-id pub-id-type="pmid">22234183</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>PI</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Inhibitory autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase analyzed by site-directed mutagenesis</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>17216</fpage><lpage>17224</lpage><pub-id pub-id-type="pmid">1324926</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CaMKII: claiming center stage in postsynaptic function and organization</article-title><source>Neuron</source><volume>81</volume><fpage>249</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.024</pub-id><pub-id pub-id-type="pmid">24462093</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodges</surname><given-names>JL</given-names></name><name><surname>Vilchez</surname><given-names>SM</given-names></name><name><surname>Asmussen</surname><given-names>H</given-names></name><name><surname>Whitmore</surname><given-names>LA</given-names></name><name><surname>Horwitz</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>α-Actinin-2 mediates spine morphology and assembly of the post-synaptic density in hippocampal neurons</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e101770</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0101770</pub-id><pub-id pub-id-type="pmid">25007055</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojjati</surname><given-names>MR</given-names></name><name><surname>van Woerden</surname><given-names>GM</given-names></name><name><surname>Tyler</surname><given-names>WJ</given-names></name><name><surname>Giese</surname><given-names>KP</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L</given-names></name><name><surname>Elgersma</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Kinase activity is not required for alphaCaMKII-dependent presynaptic plasticity at CA3-CA1 synapses</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>1125</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1038/nn1946</pub-id><pub-id pub-id-type="pmid">17660813</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalan-Sakrikar</surname><given-names>N</given-names></name><name><surname>Bartlett</surname><given-names>RK</given-names></name><name><surname>Baucum</surname><given-names>AJ</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Substrate-selective and calcium-independent activation of CaMKII by α-actinin</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>15275</fpage><lpage>15283</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.351817</pub-id><pub-id pub-id-type="pmid">22427672</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebschner</surname><given-names>D</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Baker</surname><given-names>ML</given-names></name><name><surname>Bunkóczi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Hintze</surname><given-names>B</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Oeffner</surname><given-names>RD</given-names></name><name><surname>Poon</surname><given-names>BK</given-names></name><name><surname>Prisant</surname><given-names>MG</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name><name><surname>Sammito</surname><given-names>MD</given-names></name><name><surname>Sobolev</surname><given-names>OV</given-names></name><name><surname>Stockwell</surname><given-names>DH</given-names></name><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Urzhumtsev</surname><given-names>AG</given-names></name><name><surname>Videau</surname><given-names>LL</given-names></name><name><surname>Williams</surname><given-names>CJ</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</article-title><source>Acta Crystallographica. Section D, Structural Biology</source><volume>75</volume><fpage>861</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1107/S2059798319011471</pub-id><pub-id pub-id-type="pmid">31588918</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Man</surname><given-names>H</given-names></name><name><surname>Ju</surname><given-names>W</given-names></name><name><surname>Trimble</surname><given-names>WS</given-names></name><name><surname>MacDonald</surname><given-names>JF</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons</article-title><source>Neuron</source><volume>29</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00194-5</pub-id><pub-id pub-id-type="pmid">11182095</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>JH</given-names></name><name><surname>Fu</surname><given-names>ZY</given-names></name><name><surname>Losi</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>BG</given-names></name><name><surname>Prybylowski</surname><given-names>K</given-names></name><name><surname>Vissel</surname><given-names>B</given-names></name><name><surname>Vicini</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture</article-title><source>Neuropharmacology</source><volume>42</volume><fpage>306</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/s0028-3908(01)00188-5</pub-id><pub-id pub-id-type="pmid">11897109</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matt</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Hergarden</surname><given-names>AC</given-names></name><name><surname>Patriarchi</surname><given-names>T</given-names></name><name><surname>Malik</surname><given-names>ZA</given-names></name><name><surname>Park</surname><given-names>DK</given-names></name><name><surname>Chowdhury</surname><given-names>D</given-names></name><name><surname>Buonarati</surname><given-names>OR</given-names></name><name><surname>Henderson</surname><given-names>PB</given-names></name><name><surname>Gökçek Saraç</surname><given-names>Ç</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mohapatra</surname><given-names>D</given-names></name><name><surname>Horne</surname><given-names>MC</given-names></name><name><surname>Ames</surname><given-names>JB</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>α-Actinin anchors PSD-95 at postsynaptic sites</article-title><source>Neuron</source><volume>97</volume><fpage>1094</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.036</pub-id><pub-id pub-id-type="pmid">29429936</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>F</given-names></name><name><surname>Bossio</surname><given-names>A</given-names></name><name><surname>Marzo</surname><given-names>A</given-names></name><name><surname>Ciani</surname><given-names>L</given-names></name><name><surname>Sibilla</surname><given-names>S</given-names></name><name><surname>Hannan</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>GA</given-names></name><name><surname>Palomer</surname><given-names>E</given-names></name><name><surname>Smart</surname><given-names>TG</given-names></name><name><surname>Gibb</surname><given-names>A</given-names></name><name><surname>Salinas</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Wnt signaling mediates LTP-Dependent spine plasticity and AMPAR localization through Frizzled-7 receptors</article-title><source>Cell Reports</source><volume>23</volume><fpage>1060</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.119</pub-id><pub-id pub-id-type="pmid">29694885</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SG</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Distinct forebrain and cerebellar isozymes of type II Ca2+/calmodulin-dependent protein kinase associate differently with the postsynaptic density fraction</article-title><source>The Journal of Biological Chemistry</source><volume>260</volume><fpage>9039</fpage><lpage>9046</lpage><pub-id pub-id-type="pmid">4019461</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhina</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Murata-Hori</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Alpha-actinin is required for tightly regulated remodeling of the actin cortical network during cytokinesis</article-title><source>Developmental Cell</source><volume>13</volume><fpage>554</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.08.003</pub-id><pub-id pub-id-type="pmid">17925230</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JB</given-names></name><name><surname>Zaegel</surname><given-names>V</given-names></name><name><surname>Coultrap</surname><given-names>SJ</given-names></name><name><surname>Miller</surname><given-names>AP</given-names></name><name><surname>Bayer</surname><given-names>KU</given-names></name><name><surname>Reichow</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The CaMKII holoenzyme structure in activation-competent conformations</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15742</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15742</pub-id><pub-id pub-id-type="pmid">28589927</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>H</given-names></name><name><surname>Lasda</surname><given-names>E</given-names></name><name><surname>Bayer</surname><given-names>KU</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>4656</fpage><lpage>4665</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-03-0252</pub-id><pub-id pub-id-type="pmid">16928958</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omkumar</surname><given-names>RV</given-names></name><name><surname>Kiely</surname><given-names>MJ</given-names></name><name><surname>Rosenstein</surname><given-names>AJ</given-names></name><name><surname>Min</surname><given-names>KT</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Identification of a phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>31670</fpage><lpage>31678</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.49.31670</pub-id><pub-id pub-id-type="pmid">8940188</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Özden</surname><given-names>C</given-names></name><name><surname>Sloutsky</surname><given-names>R</given-names></name><name><surname>Mitsugi</surname><given-names>T</given-names></name><name><surname>Santos</surname><given-names>N</given-names></name><name><surname>Agnello</surname><given-names>E</given-names></name><name><surname>Gaubitz</surname><given-names>C</given-names></name><name><surname>Foster</surname><given-names>J</given-names></name><name><surname>Lapinskas</surname><given-names>E</given-names></name><name><surname>Esposito</surname><given-names>EA</given-names></name><name><surname>Saneyoshi</surname><given-names>T</given-names></name><name><surname>Kelch</surname><given-names>BA</given-names></name><name><surname>Garman</surname><given-names>SC</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Stratton</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CaMKII Binds Both Substrates and Activators at the Active Site</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.10.25.354241</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özden</surname><given-names>C</given-names></name><name><surname>Sloutsky</surname><given-names>R</given-names></name><name><surname>Mitsugi</surname><given-names>T</given-names></name><name><surname>Santos</surname><given-names>N</given-names></name><name><surname>Agnello</surname><given-names>E</given-names></name><name><surname>Gaubitz</surname><given-names>C</given-names></name><name><surname>Foster</surname><given-names>J</given-names></name><name><surname>Lapinskas</surname><given-names>E</given-names></name><name><surname>Esposito</surname><given-names>EA</given-names></name><name><surname>Saneyoshi</surname><given-names>T</given-names></name><name><surname>Kelch</surname><given-names>BA</given-names></name><name><surname>Garman</surname><given-names>SC</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Stratton</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CaMKII binds both substrates and activators at the active site</article-title><source>Cell Reports</source><volume>40</volume><elocation-id>111064</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111064</pub-id><pub-id pub-id-type="pmid">35830796</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Stengel</surname><given-names>F</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Gold</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular basis of AKAP79 regulation by calmodulin</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1681</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01715-w</pub-id><pub-id pub-id-type="pmid">29162807</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patton</surname><given-names>BL</given-names></name><name><surname>Miller</surname><given-names>SG</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Activation of type II calcium/calmodulin-dependent protein kinase by Ca2+/calmodulin is inhibited by autophosphorylation of threonine within the calmodulin-binding domain</article-title><source>The Journal of Biological Chemistry</source><volume>265</volume><fpage>11204</fpage><lpage>11212</lpage><pub-id pub-id-type="pmid">2162838</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellicena</surname><given-names>P</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CaMKII inhibitors: from research tools to therapeutic agents</article-title><source>Frontiers in Pharmacology</source><volume>5</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2014.00021</pub-id><pub-id pub-id-type="pmid">24600394</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penny</surname><given-names>CJ</given-names></name><name><surname>Gold</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms for localising calcineurin and CaMKII in dendritic spines</article-title><source>Cellular Signalling</source><volume>49</volume><fpage>46</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2018.05.010</pub-id><pub-id pub-id-type="pmid">29847775</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putkey</surname><given-names>JA</given-names></name><name><surname>Waxham</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A peptide model for calmodulin trapping by calcium/calmodulin-dependent protein kinase II</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>29619</fpage><lpage>29623</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.47.29619</pub-id><pub-id pub-id-type="pmid">8939892</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>1217</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-04-01217.1998</pub-id><pub-id pub-id-type="pmid">9454832</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rellos</surname><given-names>P</given-names></name><name><surname>Pike</surname><given-names>ACW</given-names></name><name><surname>Niesen</surname><given-names>FH</given-names></name><name><surname>Salah</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>von Delft</surname><given-names>F</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000426</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000426</pub-id><pub-id pub-id-type="pmid">20668654</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes Gaido</surname><given-names>OE</given-names></name><name><surname>Nkashama</surname><given-names>LJ</given-names></name><name><surname>Schole</surname><given-names>KL</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Umapathi</surname><given-names>P</given-names></name><name><surname>Mesubi</surname><given-names>OO</given-names></name><name><surname>Konstantinidis</surname><given-names>K</given-names></name><name><surname>Luczak</surname><given-names>ED</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>CaMKII as a therapeutic target in cardiovascular disease</article-title><source>Annual Review of Pharmacology and Toxicology</source><volume>63</volume><fpage>249</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-051421-111814</pub-id><pub-id pub-id-type="pmid">35973713</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robison</surname><given-names>AJ</given-names></name><name><surname>Bartlett</surname><given-names>RK</given-names></name><name><surname>Bass</surname><given-names>MA</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2005">2005a</year><article-title>Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>39316</fpage><lpage>39323</lpage><pub-id pub-id-type="doi">10.1074/jbc.M508189200</pub-id><pub-id pub-id-type="pmid">16172120</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robison</surname><given-names>AJ</given-names></name><name><surname>Bass</surname><given-names>MA</given-names></name><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>MacMillan</surname><given-names>LB</given-names></name><name><surname>Carmody</surname><given-names>LC</given-names></name><name><surname>Bartlett</surname><given-names>RK</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2005">2005b</year><article-title>Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>35329</fpage><lpage>35336</lpage><pub-id pub-id-type="doi">10.1074/jbc.M502191200</pub-id><pub-id pub-id-type="pmid">16120608</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Ehlenberger</surname><given-names>DB</given-names></name><name><surname>Dickstein</surname><given-names>DL</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Wearne</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e1997</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001997</pub-id><pub-id pub-id-type="pmid">18431482</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saneyoshi</surname><given-names>T</given-names></name><name><surname>Matsuno</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Murakoshi</surname><given-names>H</given-names></name><name><surname>Hedrick</surname><given-names>NG</given-names></name><name><surname>Agnello</surname><given-names>E</given-names></name><name><surname>O’Connell</surname><given-names>R</given-names></name><name><surname>Stratton</surname><given-names>MM</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reciprocal activation within a kinase-effector complex underlying persistence of structural LTP</article-title><source>Neuron</source><volume>102</volume><fpage>1199</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.04.012</pub-id><pub-id pub-id-type="pmid">31078368</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanhueza</surname><given-names>M</given-names></name><name><surname>Fernandez-Villalobos</surname><given-names>G</given-names></name><name><surname>Stein</surname><given-names>IS</given-names></name><name><surname>Kasumova</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Bayer</surname><given-names>KU</given-names></name><name><surname>Otmakhov</surname><given-names>N</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Lisman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>9170</fpage><lpage>9178</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1250-11.2011</pub-id><pub-id pub-id-type="pmid">21697368</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanhueza</surname><given-names>M</given-names></name><name><surname>Lisman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The CaMKII/NMDAR complex as a molecular memory</article-title><source>Molecular Brain</source><volume>6</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/1756-6606-6-10</pub-id><pub-id pub-id-type="pmid">23410178</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savitsky</surname><given-names>P</given-names></name><name><surname>Bray</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>CDO</given-names></name><name><surname>Marsden</surname><given-names>BD</given-names></name><name><surname>Mahajan</surname><given-names>P</given-names></name><name><surname>Burgess-Brown</surname><given-names>NA</given-names></name><name><surname>Gileadi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>High-throughput production of human proteins for crystallization: the SGC experience</article-title><source>Journal of Structural Biology</source><volume>172</volume><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2010.06.008</pub-id><pub-id pub-id-type="pmid">20541610</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahi</surname><given-names>K</given-names></name><name><surname>Baudry</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Glycine-induced changes in synaptic efficacy in hippocampal slices involve changes in AMPA receptors</article-title><source>Brain Research</source><volume>627</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(93)90329-l</pub-id><pub-id pub-id-type="pmid">8298970</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Teruel</surname><given-names>MN</given-names></name><name><surname>Subramanian</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines</article-title><source>Neuron</source><volume>21</volume><fpage>593</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80569-3</pub-id><pub-id pub-id-type="pmid">9768845</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singla</surname><given-names>SI</given-names></name><name><surname>Hudmon</surname><given-names>A</given-names></name><name><surname>Goldberg</surname><given-names>JM</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Molecular characterization of calmodulin trapping by calcium/calmodulin-dependent protein kinase II</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>29353</fpage><lpage>29360</lpage><pub-id pub-id-type="doi">10.1074/jbc.M101744200</pub-id><pub-id pub-id-type="pmid">11384969</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjöblom</surname><given-names>B</given-names></name><name><surname>Salmazo</surname><given-names>A</given-names></name><name><surname>Djinović-Carugo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Alpha-actinin structure and regulation</article-title><source>Cellular and Molecular Life Sciences</source><volume>65</volume><fpage>2688</fpage><lpage>2701</lpage><pub-id pub-id-type="doi">10.1007/s00018-008-8080-8</pub-id><pub-id pub-id-type="pmid">18488141</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skubák</surname><given-names>P</given-names></name><name><surname>Araç</surname><given-names>D</given-names></name><name><surname>Bowler</surname><given-names>MW</given-names></name><name><surname>Correia</surname><given-names>AR</given-names></name><name><surname>Hoelz</surname><given-names>A</given-names></name><name><surname>Larsen</surname><given-names>S</given-names></name><name><surname>Leonard</surname><given-names>GA</given-names></name><name><surname>McCarthy</surname><given-names>AA</given-names></name><name><surname>McSweeney</surname><given-names>S</given-names></name><name><surname>Mueller-Dieckmann</surname><given-names>C</given-names></name><name><surname>Otten</surname><given-names>H</given-names></name><name><surname>Salzman</surname><given-names>G</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and A poor starting model</article-title><source>IUCrJ</source><volume>5</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1107/S2052252517017961</pub-id><pub-id pub-id-type="pmid">29765606</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strack</surname><given-names>S</given-names></name><name><surname>McNeill</surname><given-names>RB</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2000">2000a</year><article-title>Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>23798</fpage><lpage>23806</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001471200</pub-id><pub-id pub-id-type="pmid">10764765</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strack</surname><given-names>S</given-names></name><name><surname>Robison</surname><given-names>AJ</given-names></name><name><surname>Bass</surname><given-names>MA</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2000">2000b</year><article-title>Association of calcium/calmodulin-dependent kinase II with developmentally regulated splice variants of the postsynaptic density protein densin-180</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>25061</fpage><lpage>25064</lpage><pub-id pub-id-type="doi">10.1074/jbc.C000319200</pub-id><pub-id pub-id-type="pmid">10827168</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studier</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Protein production by auto-induction in high density shaking cultures</article-title><source>Protein Expression and Purification</source><volume>41</volume><fpage>207</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2005.01.016</pub-id><pub-id pub-id-type="pmid">15915565</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Hoek</surname><given-names>H</given-names></name><name><surname>Klena</surname><given-names>N</given-names></name><name><surname>Jordan</surname><given-names>MA</given-names></name><name><surname>Alvarez Viar</surname><given-names>G</given-names></name><name><surname>Righetto</surname><given-names>RD</given-names></name><name><surname>Schaffer</surname><given-names>M</given-names></name><name><surname>Erdmann</surname><given-names>PS</given-names></name><name><surname>Wan</surname><given-names>W</given-names></name><name><surname>Geimer</surname><given-names>S</given-names></name><name><surname>Plitzko</surname><given-names>JM</given-names></name><name><surname>Baumeister</surname><given-names>W</given-names></name><name><surname>Pigino</surname><given-names>G</given-names></name><name><surname>Hamel</surname><given-names>V</given-names></name><name><surname>Guichard</surname><given-names>P</given-names></name><name><surname>Engel</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>In situ architecture of the ciliary base reveals the stepwise assembly of intraflagellar transport trains</article-title><source>Science</source><volume>377</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1126/science.abm6704</pub-id><pub-id pub-id-type="pmid">35901159</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walikonis</surname><given-names>RS</given-names></name><name><surname>Jensen</surname><given-names>ON</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Provance</surname><given-names>DW</given-names><suffix>Jr</suffix></name><name><surname>Mercer</surname><given-names>JA</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification of proteins in the postsynaptic density fraction by mass spectrometry</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>4069</fpage><lpage>4080</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-11-04069.2000</pub-id><pub-id pub-id-type="pmid">10818142</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walikonis</surname><given-names>RS</given-names></name><name><surname>Oguni</surname><given-names>A</given-names></name><name><surname>Khorosheva</surname><given-names>EM</given-names></name><name><surname>Jeng</surname><given-names>CJ</given-names></name><name><surname>Asuncion</surname><given-names>FJ</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Densin-180 forms a ternary complex with the (alpha)-subunit of Ca2+/calmodulin-dependent protein kinase II and (alpha)-actinin</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-02-00423.2001</pub-id><pub-id pub-id-type="pmid">11160423</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxham</surname><given-names>MN</given-names></name><name><surname>Tsai</surname><given-names>AL</given-names></name><name><surname>Putkey</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A mechanism for calmodulin (CaM) trapping by CaM-kinase II defined by A family of CaM-binding peptides</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>17579</fpage><lpage>17584</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.28.17579</pub-id><pub-id pub-id-type="pmid">9651352</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>G</given-names></name><name><surname>Waterman</surname><given-names>DG</given-names></name><name><surname>Parkhurst</surname><given-names>JM</given-names></name><name><surname>Brewster</surname><given-names>AS</given-names></name><name><surname>Gildea</surname><given-names>RJ</given-names></name><name><surname>Gerstel</surname><given-names>M</given-names></name><name><surname>Fuentes-Montero</surname><given-names>L</given-names></name><name><surname>Vollmar</surname><given-names>M</given-names></name><name><surname>Michels-Clark</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>ID</given-names></name><name><surname>Sauter</surname><given-names>NK</given-names></name><name><surname>Evans</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>DIALS: implementation and evaluation of a new integration package</article-title><source>Acta Crystallographica. Section D, Structural Biology</source><volume>74</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1107/S2059798317017235</pub-id><pub-id pub-id-type="pmid">29533234</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyszynski</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Nigh</surname><given-names>E</given-names></name><name><surname>Beggs</surname><given-names>AH</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Competitive binding of alpha-actinin and calmodulin to the NMDA receptor</article-title><source>Nature</source><volume>385</volume><fpage>439</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/385439a0</pub-id><pub-id pub-id-type="pmid">9009191</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyszynski</surname><given-names>M</given-names></name><name><surname>Kharazia</surname><given-names>V</given-names></name><name><surname>Shanghvi</surname><given-names>R</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Beggs</surname><given-names>AH</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name><name><surname>Weinberg</surname><given-names>R</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Differential regional expression and ultrastructural localization of alpha-actinin-2, a putative NMDA receptor-anchoring protein, in rat brain</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>1383</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-04-01383.1998</pub-id><pub-id pub-id-type="pmid">9454847</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>R</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CaMKII: a central molecular organizer of synaptic plasticity, learning and memory</article-title><source>Nature Reviews. Neuroscience</source><volume>23</volume><fpage>666</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41583-022-00624-2</pub-id><pub-id pub-id-type="pmid">36056211</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>Bañuelos</surname><given-names>S</given-names></name><name><surname>Gautel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Molecular structure of the sarcomeric Z-disk: two types of titin interactions lead to an asymmetrical sorting of alpha-actinin</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>1614</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.6.1614</pub-id><pub-id pub-id-type="pmid">9501083</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">TOP10 chemically competent</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat# C404003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21 (DE3)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# EC0114</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21 Tuner (DE3) pLysS</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# 70624</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21 Star (DE3)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# C601003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">Cat# CRL-3216</td><td align="left" valign="bottom">Verified using STR profiling, <italic>Mycoplasma</italic>-tested</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Rattus norvegicus</italic>)</td><td align="left" valign="bottom">Sprague-Dawley rat</td><td align="left" valign="bottom">UCL breeding colony</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-GFP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SAB4301138; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2750576">AB_2750576</ext-link></td><td align="left" valign="bottom">10 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-FLAG</td><td align="left" valign="bottom">Novus</td><td align="left" valign="bottom">Cat# NB600-344; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000565">AB_10000565</ext-link></td><td align="left" valign="bottom">5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-GST</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# G7781; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_259965">AB_259965</ext-link></td><td align="left" valign="bottom">0.2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-CaMKIIα</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-32288; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_626787">AB_626787</ext-link></td><td align="left" valign="bottom">0.2 μg/mL for IB; 0.5 μg/mL for ICC</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-HA</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab9110; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_307019">AB_307019</ext-link></td><td align="left" valign="bottom">2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-V5</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# MA5-15253; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10977225">AB_10977225</ext-link></td><td align="left" valign="bottom">2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-rabbit HRP-linked secondary antibody</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 7074 S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2099233">AB_2099233</ext-link></td><td align="left" valign="bottom">0.5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-mouse HRP secondary antibody</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 32230; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1965958">AB_1965958</ext-link></td><td align="left" valign="bottom">0.5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-rabbit Alexa Fluor-405</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-31556; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221605">AB_221605</ext-link></td><td align="left" valign="bottom">4 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Duolink In Situ PLA Probe, Donkey Polyclonal Anti-Goat PLUS</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# DUO92003</td><td align="left" valign="bottom">At 1x final concentration according to the manufacturer’s guidelines.</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Duolink In Situ PLA Probe, Donkey Polyclonal Anti-Mouse MINUS</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# DUO92004</td><td align="left" valign="bottom">At 1x final concentration according to the manufacturer’s guidelines.</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Duolink In Situ PLA Probe, Donkey Polyclonal Anti-Rabbit MINUS</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# DUO92005</td><td align="left" valign="bottom">At 1x final concentration according to the manufacturer’s guidelines.</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-GFP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SAB4301138; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2750576">AB_2750576</ext-link></td><td align="left" valign="bottom">10 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-FLAG</td><td align="left" valign="bottom">Novus</td><td align="left" valign="bottom">Cat# NB600-344; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000565">AB_10000565</ext-link></td><td align="left" valign="bottom">5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-GST</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# G7781; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_259965">AB_259965</ext-link></td><td align="left" valign="bottom">0.2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse anti-CaMKIIα</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-32288; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_626787">AB_626787</ext-link></td><td align="left" valign="bottom">0.2 μg/mL for IB; 0.5 μg/mL for ICC</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-HA</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab9110; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_307019">AB_307019</ext-link></td><td align="left" valign="bottom">2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse anti-V5</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# MA5-15253; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10977225">AB_10977225</ext-link></td><td align="left" valign="bottom">2 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit HRP-linked secondary antibody</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 7074 S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2099233">AB_2099233</ext-link></td><td align="left" valign="bottom">0.5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-mouse poly-HRP secondary antibody</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 32230; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1965958">AB_1965958</ext-link></td><td align="left" valign="bottom">0.5 μg/mL</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit Alexa Fluor-405</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-31556; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221605">AB_221605</ext-link></td><td align="left" valign="bottom">4 μg/mL</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pIRES2-EGFP</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Cat# 6029-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pIRES2-EGFP-FLAG-α-actinin-2 construct series (1–894; 1–748; 747–894; 747–890; 1–890; 747–894 L854R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pcDNA3.1-6His-CaMKIIα</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pIRES2-EGFP-V5-CaMKIIα<break/>(WT, T286A, T305A, and T306A variants)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET28-6His-GST-Tev- actinin-2 EF3–4 (827–894)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pNH-TrxT-6His-Trx-Tev-CaMKIIα (1–315)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEX6P1-α-actinin-2 EF1–4 (747–894)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEX6P1-GluN2B (1260–1492)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET28-CaM (untagged)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib41">Patel et al., 2017</xref></td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCI-EGFP-NR2B</td><td align="left" valign="bottom">Andres Barria and Robert Malinow/Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_45447">Addgene_45447</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFP-NR2B vector</td><td align="left" valign="bottom">Stefano Vicini/Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_17925">Addgene_17925</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEGFP-NR2B-iHA (WT and ΔCaMKII variants)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Contact MGG to obtain this vector</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pNH-TrxT</td><td align="left" valign="bottom">Opher Gileadi/Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_26106">Addgene_26106</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET3d-6His-α-actinin-2</td><td align="left" valign="bottom">Kristina Djinović-Carugo (<xref ref-type="bibr" rid="bib14">de Ribeiro et al., 2014</xref>)</td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Lipofectamine 2000</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 11668019</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Polyethylenimine (linear, MW25000)</td><td align="left" valign="bottom">Polysciences</td><td align="left" valign="bottom">Cat# 23966</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Duolink In Situ Detection Reagents Red</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">Cat# DUO92008</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Pierce Glutathione Magnetic Agarose Beads</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 78601</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM, high glucose, pyruvate</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 41966029</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trypsin</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 25300054</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Penicillin/Streptomycin</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 15140122</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GlutaMAX</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 35050061</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DPBS, no calcium, no magnesium</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 14190144</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Neurobasal-A medium</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 10888022</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">B27 supplement</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 17504044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Poly-L-Lysine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# P2636</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Complete, Mini, EDTA-free Protease Inhibitor Cocktail</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 11836170001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ (version 1.52)</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">NeuronStudio</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Rodriguez et al., 2008</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://icahn.mssm.edu">https://icahn.mssm.edu</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013798">SCR_013798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Origin</td><td align="left" valign="bottom">OriginLab</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014212">SCR_014212</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85008.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Saneyoshi</surname><given-names>Takeo</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Kyoto University</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.12.04.519035" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.04.519035"/></front-stub><body><p>This fundamental study substantially advances our understanding of the synaptic targeting of a major postsynaptic protein kinase, CaMKII, that underlies the persistence of excitatory synaptic strength in synaptic plasticity. The evidence for the authors' claims is compelling, with cell biological, biochemical, as well as structural biological approaches. This work will be of broad interest to cell and computational biologists working on learning/memory.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85008.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Saneyoshi</surname><given-names>Takeo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Kyoto University</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Hell</surname><given-names>Johannes W</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.04.519035">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.12.04.519035v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Molecular basis of interactions between CaMKII and α-actinin-2 that underlie dendritic spine enlargement&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Volker Dötsch as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Johannes W Hell (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>As you will see in the comments below, the reviewers find the model that synaptic localization of CaMKII and α-actinin-2 complex during structural LTP that is cooperated by interaction with the NMDAR subunit GluN2B is of broad interest. As it stands, all three reviewers agree that the results are convincing but would require the inclusion of additional studies and clarification of the model, in particular with respect to its co-localization of GluN2B as well as the roles of autophosphorylation of CaMKII, before they could recommend publication in <italic>eLife</italic>.</p><p>All reviewers reached a consensus to ask the authors for revision as follows:</p><p>1) the PLA assay between α-actinin-2 and either CaMKII (as already partially done) or GluN2B should be done.</p><p>2) The effects of autophosphorylation sites (T286, T305, T306) of CaMKII have to be tested individually in the neuron.</p><p>3) Time course study for the puncta formation of the complex, such as CaMKII/GluN2B, CaMKII/ α-actinin-2, or GluN2B/ α-actinin-2. It does not have to show the three proteins together.</p><p>4) Regarding the roles for EF1 and 2 in α-actinin-2 co-localization with CaMKII in the neuron (Item2 of reviewer 3), the interpretation of the role of EF1/2 in the absence of any new supportive data would be overestimating. The contribution of EF1/2 can be addressed by the PLA assay with α-actinin-2 mutants such as δ-EF1/2, δ-EF3/4, or δ-EF1-4 in Figure 1. Alternatively, just soften the interpretations of the existing data.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. Why did the authors use proximity ligation assays (PLAs) to detect the interaction between CaMKII and α-actinin-2? Is this method able to compare the amount of GluN2B and α-actinin-2 in the complex with CaMKII at synapse during LTP? If so, it will be useful to the author's proposal.</p><p>2. Are GluN2B binding to CaMKII or phosphorylation on T286 of CaMKII associated with affinity to α-actinin-2?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The authors equate an increase in PLA signal as an increase in aACTN binding to CaMKII; however, PLA is only a measure of proximity but not necessarily of a specific interaction. This aspect needs to be clearly spelled out and taken into account in the interpretations of the results.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Additional studies could be performed to provide more substantial support for the model presented.</p><p>1. A central part of the final model is that GluN2B stabilizes the CaMKII-actinin complex. However, the manuscript contains no data to show that CaMKII-binding to GluN2B is important for CaMKII-actinin colocalization, or even to show that GluN2B colocalizes with the CaMKII-actinin complexes.. The impact of the study would be significantly enhanced by additional neuronal studies to demonstrate the importance of GluN2B in CaMKII-actinin colocalization.</p><p>2. The current in vitro and structural data confirm the critical role of actinin EF3 and EF4 domains in binding to the CaMKII regulatory domain, and further indicate that the actinin EF1 and EF2 domains can increase the affinity ~3-fold. This seems like a rather modest effect and the interpretation is critically dependent on the precise determination of the concentrations of the various proteins. However, the methods do not seem to specify how protein concentrations were determined and do not indicate whether experimental replicates were conducted with the same protein preparation or independently prepared preparations. Furthermore, there is no evidence that EF1/2 domains specifically play a role in CaMKII-actinin colocalization in neurons and dendritic spine enlargement. The impact of the study would be significantly enhanced by additional studies testing the role of EF1 and EF2 in neurons.</p><p>3. Prior studies have found that CaMKII autophosphorylation at Thr286, Thr305 and Thr306 dynamically modulate CaMKII targeting to the synapse. Specifically: 1. Autophosphorylation at Thr286 modulates CaMKII binding to GluN2B, apparently with little direct effect on binding to actinin; but, there may be an indirect effect on CaMKII-actinin colocalization mediated by changes in GluN2B binding. 2. Autophosphorylation at Thr305 OR Thr306 can interfere with CaM binding, but only Thr306 autophosphorylation interferes with actinin binding. However, the mechanism underlying the disruption of postsynaptic targeting by autophosphorylation at Thr305 and/or Thr306 is unclear. The final model predicts that autophosphorylation at each of these sites may modulate CaMKII-actinin interaction. The impact of the study would be significantly enhanced by additional studies using T286A, T305A, and T306A mutant CaMKIIs to determine the role of autophosphorylation at these sites on actinin-CaMKII colocalization and the spine size.</p><p>4. There is a concern about the apparent use of t-tests in all studies, even when multiple comparisons are being made in some datasets. Wouldn't ANOVAs be more appropriate?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85008.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>As you will see in the comments below, the reviewers find the model that synaptic localization of CaMKII and α-actinin-2 complex during structural LTP that is cooperated by interaction with the NMDAR subunit GluN2B is of broad interest. As it stands, all three reviewers agree that the results are convincing but would require the inclusion of additional studies and clarification of the model, in particular with respect to its co-localization of GluN2B as well as the roles of autophosphorylation of CaMKII, before they could recommend publication in eLife.</p><p>All reviewers reached a consensus to ask the authors for revision as follows:</p><p>1) the PLA assay between α-actinin-2 and either CaMKII (as already partially done) or GluN2B should be done.</p><p>2) The effects of autophosphorylation sites (T286, T305, T306) of CaMKII have to be tested individually in the neuron.</p><p>3) Time course study for the puncta formation of the complex, such as CaMKII/GluN2B, CaMKII/ α-actinin-2, or GluN2B/ α-actinin-2. It does not have to show the three proteins together.</p><p>4) Regarding the roles for EF1 and 2 in α-actinin-2 co-localization with CaMKII in the neuron (Item2 of reviewer 3), the interpretation of the role of EF1/2 in the absence of any new supportive data would be overestimating. The contribution of EF1/2 can be addressed by the PLA assay with α-actinin-2 mutants such as δ-EF1/2, δ-EF3/4, or δ-EF1-4 in Figure 1. Alternatively, just soften the interpretations of the existing data.</p></disp-quote><p>We have performed additional experiments as requested. Regarding each of these four points: (1) We have performed new PLA experiments to monitor interactions between GluN2B subunits and either CaMKII (Figure 6G and Figure 6—figure supplement 2) or α-actinin-2 (Figure 6H and Figure 6—figure supplement 3). We have also undertaken further analysis of our existing PLA data for interactions between a-actinin-2 and CaMKII to establish the frequency of puncta formation by spine type before and after NMDAR activation (Figure 1—figure supplement 2). (2) We have completed PLA experiments comparing interaction of V5-CaMKIIα WT/T286A/T305A/T306A and FLAG-a-actinin-2 (Figure 2B and C, Figure 2—figure supplement 2). (3) We now include time-course PLA measurements to establish how quickly CaMKIIα and α-actinin-2 associate following NDMAR activation (Figure 2A and Figure 2—figure supplement 1). (4) We have softened the interpretation of our existing data regarding the contribution of EF hands 1-2 (lines 457-459). These additions to our study are described in detail in the point-by-point responses to each reviewer.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. Why did the authors use proximity ligation assays (PLAs) to detect the interaction between CaMKII and α-actinin-2? Is this method able to compare the amount of GluN2B and α-actinin-2 in the complex with CaMKII at synapse during LTP? If so, it will be useful to the author's proposal.</p></disp-quote><p>As recommended by the editor, and in line with the reviewer’s comment, we have performed additional PLA experiments to investigate interactions between CaMKII and GluN2B subunits before and after NMDAR activation. The results of these experiments are shown in Figure 6 panels F-H, and in Figure 6—figure supplements 2 and 3. We generated a vector for expression of GFP-GluN2B bearing an internal HA tag near to the CaMKII binding site (Figure 6F) that enabled us to monitor interactions between the receptor subunit and either CaMKII (Figure 6G) and a-actinin-2 (Figure 6H). We found that in both cases interactions were elevated following NMDAR activation, and that mutation of the CaMKII docking site in GluN2B suppressed the extent to which interactions with both α-actinin-2 and CaMKII were elevated following NMDAR activation. In addition to the new figures, we have included text related to these experiments in the results (lines 389-419) and methods (lines 602-605) sections, and figure legends for the new figures are provided on lines 1063-1070, 1167-1172, and 11741180.</p><disp-quote content-type="editor-comment"><p>2. Are GluN2B binding to CaMKII or phosphorylation on T286 of CaMKII associated with affinity to α-actinin-2?</p></disp-quote><p>In our revised submission, we include new experiments to investigate whether T286 phosphorylation is required for interactions between CaMKII and α-actinin-2. The results of these experiments are shown in Figure 2B and C and Figure 2—figure supplement 2. We used PLA to monitor interactions between V5-CaMKIIa variants and FLAG-α-actinin-2. Incorporation of the phospho-null mutation T286A in CaMKIIα did not alter PLA puncta formation relative to WT CaMKIIα in either neurons before or after NMDAR activation. These results are discussed in full on lines 151-177. We have also updated the methods section on lines 598-601 and 627, and new figure legends are provided on lines 1014-1020, and 1109-11106. New experiments investigating the role of GluN2B binding to CaMKII are described in Reviewer 1, point1.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The authors equate an increase in PLA signal as an increase in aACTN binding to CaMKII; however, PLA is only a measure of proximity but not necessarily of a specific interaction. This aspect needs to be clearly spelled out and taken into account in the interpretations of the results.</p></disp-quote><p>The reviewer raises an important point that positive PLA signal does not necessarily indicate direct protein-protein interaction since rolling circle amplification can occur when the target protein pair is separated up to a maximum theoretical distance of 40 nm (Trifilieff et al., Biotechniques, 2011, PMID 21806555; https://www.sigmaaldrich.com/GB/en/products/protein-biology/duolinkproximity-ligation-assay). In the case of experiments focused on interactions between α-actinin-2 and CaMKII, we included controls including imaging with α-actinin-2 constructs lacking the EF1-4 region (Figure 1D), and an EF1-4 construct bearing mutations to prevent association with CaMKII (Figure 2—figure supplement 1C). These experiments indicate that the PLA puncta we observe are likely to correspond to direct interactions between α-actinin-2 and CaMKII. We have included the following additional text on lines 123-125 to explain how the limitations of PLA should be factored into the interpretation of our results: “Although PLA signal is a measure of protein proximity rather than direct protein-protein interaction, the low levels of puncta formation observed with the ∆EF1-4 construct indicate that puncta formation in this case is likely to correspond to direct interaction between CaMKII and α-actinin-2”.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Additional studies could be performed to provide more substantial support for the model presented.</p><p>1. A central part of the final model is that GluN2B stabilizes the CaMKII-actinin complex. However, the manuscript contains no data to show that CaMKII-binding to GluN2B is important for CaMKII-actinin colocalization, or even to show that GluN2B colocalizes with the CaMKII-actinin complexes.. The impact of the study would be significantly enhanced by additional neuronal studies to demonstrate the importance of GluN2B in CaMKII-actinin colocalization.</p></disp-quote><p>To investigate the role of GluN2B interactions with CaMKII and a-actinin-2, we have generated a new construct – GFP-GluN2B-iHA – that includes an internal HA tag to enable in situ PLA assays of interactions to the GluN2B C-terminal tail (Figure 6F). Our revised submission includes two sets of experiments using WT and ∆CaMKII (L1298A/R1300Q) variants of this construct to monitor interactions with CaMKII (Figure 6G and Figure 6—figure supplement 2) and α-actinin-2 (Figure 6H and Figure 6—figure supplement 3). We found that PLA puncta formation indicative of GluN2B-CaMKII interaction was elevated as expected following NMDAR activation, and that this effect was attenuated by mutation of the CaMKII anchoring site. We also detected interactions between GluN2B and α-actinin-2 that were elevated (to a lesser extent) upon NMDAR activation. Mutation of the GluN2B CaMKII anchoring site also suppressed elevation of GluN2B-α-actinin-2 interactions following NMDAR activation. We performed two-way ANOVAs to show that there was interaction between mutation of the CaMKII anchoring site and NMDAR activation for both GluN2B-CaMKII and GluN2B-α-actinin-2 interactions. In this way, these additional experiments are consistent with the notion that CaMKII docking to GluN2B plays at least some role in increasing access to α-actinin-2 in structural LTP. These new experiments are described in full on lines 389-419. We also include additional methodological information related to these experiments on lines 602-605, and include new figure legends on lines 10631070, 1167-1172, and 1174-1180.</p><disp-quote content-type="editor-comment"><p>2. The current in vitro and structural data confirm the critical role of actinin EF3 and EF4 domains in binding to the CaMKII regulatory domain, and further indicate that the actinin EF1 and EF2 domains can increase the affinity ~3-fold. This seems like a rather modest effect and the interpretation is critically dependent on the precise determination of the concentrations of the various proteins. However, the methods do not seem to specify how protein concentrations were determined and do not indicate whether experimental replicates were conducted with the same protein preparation or independently prepared preparations. Furthermore, there is no evidence that EF1/2 domains specifically play a role in CaMKII-actinin colocalization in neurons and dendritic spine enlargement. The impact of the study would be significantly enhanced by additional studies testing the role of EF1 and EF2 in neurons.</p></disp-quote><p>To clarify our experimental approach for ITC experiments, we have included additional information in the methods section on lines 574-577, as follows: “Protein concentrations were determined using a combination of absorbance at A<sub>280</sub> (with reference to theoretical extinction coefficients) and bichinchoninic acid (BCA) assays. Single protein preparations were used for experimental replicates with the exception of EF3-4, where two preparations were used. Each preparation of EF3-4 yielded similar results”. We agree with the reviewer that the effect of including the EF1-2 region on the affinity is modest, and whether the EF1-2 hands contribute to binding the regulatory segment does not fundamentally alter the mechanism put forward in Figure 6. Therefore, we decided to prioritise timecourse experiments, and experiments involving GluN2B and CaMKII phosphorylation site mutants. In the discussion, we have included the following additional text (lines 457-459) to highlight that there is some uncertainty regarding the contribution of the EF1-2 hands: “Our ITC measurements indicate that EF1-4 binds to the CaMKII regulatory segment with somewhat higher affinity than EF3-4 (Figure 3), so there is some remaining uncertainty concerning the exact contribution of the EF1-2 region to interaction with CaMKII in neurons”.</p><disp-quote content-type="editor-comment"><p>3. Prior studies have found that CaMKII autophosphorylation at Thr286, Thr305 and Thr306 dynamically modulate CaMKII targeting to the synapse. Specifically: 1. Autophosphorylation at Thr286 modulates CaMKII binding to GluN2B, apparently with little direct effect on binding to actinin; but, there may be an indirect effect on CaMKII-actinin colocalization mediated by changes in GluN2B binding. 2. Autophosphorylation at Thr305 OR Thr306 can interfere with CaM binding, but only Thr306 autophosphorylation interferes with actinin binding. However, the mechanism underlying the disruption of postsynaptic targeting by autophosphorylation at Thr305 and/or Thr306 is unclear. The final model predicts that autophosphorylation at each of these sites may modulate CaMKII-actinin interaction. The impact of the study would be significantly enhanced by additional studies using T286A, T305A, and T306A mutant CaMKIIs to determine the role of autophosphorylation at these sites on actinin-CaMKII colocalization and the spine size.</p></disp-quote><p>We now include experiments with neurons expressing V5-tagged CaMKIIα variants (WT, T286A, T305A, or T306A) in combination with FLAG-α-actinin-2. This has enabled us to perform antiV5/Anti-FLAG PLA to determine the effect of preventing phosphorylation at each of the three sites on association of CaMKIIα and α-actinin-2, the results of which are shown in Figure 2C and Figure 2—figure supplement 2. We found that WT CaMKIIα behaved as expected, with an ~3-fold rise in PLA puncta formation upon activation of NMDARs (Figure 2C). None of the three alanine substitution variants were markedly different from WT either before or after NMDAR activation, indicating that phosphorylation at the three sites is not required for enabling or suppressing interactions between the two proteins in this context. We note in the Results section that “T286 auto-phosphorylation is thought to be particularly important in the initial induction phase of LTP following summation of multiple Ca<sup>2+</sup> transients (Yasuda et al., 2022), which is not a function that would be required using our chemical LTP protocol”. These new experiments are described in full on lines 151-177 of the Results section. We also mention the experiments later in the Results section (lines 363-364), include new methodological information related to these experiments on lines 598-602, and legends for Figure 2B and C (lines 1014-1020) Figure 2—figure supplement 2 (lines 1109-1116).</p><disp-quote content-type="editor-comment"><p>4. There is a concern about the apparent use of t-tests in all studies, even when multiple comparisons are being made in some datasets. Wouldn't ANOVAs be more appropriate?</p></disp-quote><p>In our original submission, we do not think there are instances where pair-wise t-test were used inappropriately. We have now taken advantage of two-way ANOVAs in the analysis of PLA data collected with WT and DCaMKII variants of GluN2B-iHA before and after NMDAR activation (Figure 6G and H). This was a powerful statistical approach to show an interaction between the presence of the CaMKII anchoring site in GluN2B subunit and receptor activation on interactions between GluN2B and both CaMKII and α-actinin-2 (see lines 404-419). We thank the reviewer to alerting us to the possibility of using ANOVAs in the analysis of our data.</p></body></sub-article></article>